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ABSTRACT 
A Biomedical Engineering Approach to Investigating Flow and Wall Shear Stress in 
Contracting Lymphatics. (May 2006) 
James Brandon Dixon, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Gerard L. Coté 
 
 
 
Collecting microlymphatics play a vital role in promoting lymph flow from the 
initial lymphatics in the interstitial spaces to the large transport lymph ducts.  In most 
tissues, the primary mechanism for producing this flow is the spontaneous contractions 
of the lymphatic wall. Individual units, known as lymphangion, are separated by valves 
that help prevent backflow when the vessel contracts, thus promoting flow through the 
lymphatic network.  Lymphatic contractile activity is inhibited by flow in isolated 
lymphatics, however there are virtually no in situ measurements of lymph flow in these 
vessels. Initially, a high speed imaging system was set up to image in situ preparations at 
500 fps.  These images were then manually processed to extract information regarding 
lymphocyte velocity (-4 to 10 mm/sec), vessel diameter (25 to 165 um), and particle 
location.  Fluid modeling was performed to obtain reasonable estimates of wall shear 
stress (-8 to 17 dynes/cm2). One of the difficulties encountered was the time consuming 
methods of manual particle tracking.  Using previously captured images, an image 
correlation method was developed to automate lymphatic flow measurements and to 
track wall movements as the vessel contracts.  Using this method the standard error of 
prediction for velocity measurements was 0.4 mm/sec and for diameter measurements it 
iv 
was 7.0 µm.  It was found that the actual physical quantity being measured through this 
approach is somewhere between the spatially averaged velocity and the maximum 
velocity of a Poiseuille flow model. 
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CHAPTER I 
INTRODUCTION 
 
The lymphatic system plays a crucial role in the transport of proteins and large 
particulate matter away from the interstitial spaces in the body, since the capillaries 
cannot move such particles directly by absorption.  In addition to tissue homeostasis, the 
lymphatic system also plays important, although not completely understood, roles in 
lipid transport and metabolism, and immune function [1].  Nearly all body tissues have a 
supporting lymphatic system to serve these purposes; without such a system, our bodies 
would suffer serious consequences.  About ten percent of the blood flow filtered out of 
the arterial capillaries is returned to the circulatory system after being absorbed by 
lymphatic capillaries and filtered through the lymphatic system. The total amount of 
flow through the lymph system is about two to three liters per day [1].  In mammals, the 
lymphatics push all of this fluid without the benefits of a central pumping organ like the 
heart.  Historically, the lymphatic system was treated as a system of conduits which 
transported fluid from the interstitial spaces to the thoracic duct by means of interstitial 
fluid driving pressure, now referred to as the extrinsic pump.  Certainly various factors 
influencing interstitial pressure play influential roles in the filling of lymphatics to 
increase flow.  The factors include an increased rate of lymph formation, elevated  
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capillary pressure, decreased plasma colloid osmotic pressure, increased interstitial fluid 
protein, and increased permeability of the capillaries.  
 However, several decades ago it was noticed that many lymphatics in a variety 
of mammals [2-5] and specifically humans [6-8] exhibit rhythmic contractions to aid in 
the promotion of lymph flow.  Most physiology texts now teach this as the second 
mechanism, called the intrinsic pump, as also being responsible for driving flow; 
however, the various factors that control this pump and its significance in relation to the 
specific lymphatic functions are still poorly understood and not heavily emphasized.  
This discovery of lymphatic contractility is now referred to as the intrinsic lymphatic 
pump, as compared to the extrinsic lymphatic pump discussed earlier. 
Anatomically, the vessels of the lymphatic system are divided into three 
categories: initial lymphatics, collecting lymphatics, and transport lymphatics.  The 
origins of the lymphatic system, known as the initial lymphatics, are dispersed 
throughout the capillary network of the mesentery.  The walls of the initial lymphatics 
are usually not contractile and are lined with endothelium but with no smooth muscle [9].  
The main mechanism used to fill the initial lymphatics is the extrinsic pump, which 
responds to both steady-state lymph volumes and unsteady initial lymph volumes.  
While the surrounding skeletal muscle can contract to aid in the filling of initial 
lymphatics, the steady-state response is noted to act without contraction of the initial 
lymphatics in most tissues.  It is hypothesized that this filling occurs through a 
combination of the active lymphatic wall pump downstream in the collecting lymphatics 
and favorable transient drops in fluid pressure due to contraction of surrounding skeletal 
3 
muscle and other factors from the interstitium to the lymphatic lumen [9-11]. 
Smooth muscle typically begins to line the lymphatics in the collecting 
lymphatics, where multiple initial lymphatics join together[12].  The sections of lymph 
vessels where smooth muscle is present, have the ability to perform spontaneous muscle 
contractions.  It is also near these lymphatic sites that one begins to see lymphatic valves.  
Functional units of lymphatic vessels, known as lymphagions, are arranged in series, 
each separated by valves[13-15].  These valves occur every 600-1000 µm in rat 
mesentery lymphatics and smooth muscle is always present around such valves.  The 
valves are highly competent and help prevent retrograde flow during relaxation of the 
vessel wall (Figure 1.1).  This is needed to keep unwanted fluid and proteins from 
entering back into the interstitial spaces.   
 
 
 
Figure 1.1:  Confocal microscopy image of a portion of a mesenteric lymphatic vessel 
illustrating the structure of valve leaflets. 
There are currently differing theories as to whether these valves play an active or a 
4 
passive role in the intrinsic pump [10, 16].  Either way, the presence of these valves, in 
conjunction with the active contraction cycle of individual lymphangions, makes the 
intrinsic pump highly effective for promoting flow.  
Lymphatic muscle in rat mesenteric lymphatics has been shown to possess 
important differences from other smooth muscle.  Lymphatic smooth muscle is 
composed of only SMB smooth muscle myosin heavy chain, as opposed to arterioles, 
which posses both SMB and SMA isoforms  [12].  Contraction of this smooth muscle 
propagates to push lymph from one lymphagion to the next.  Studies have been done on 
the propagation of this motion noting the phase, frequency, and amplitude of such 
contractions.  While the majority of the propagation occurs in the downstream direction, 
roughly 40% of lymphatic contractions have been shown to propagate upstream [17].  It 
is believed that the pacemaker site for these peristaltic contractions is located at the inlet 
side of the valve at each lymphagion unit [18].  However, this may not be the case in all 
lymphatics.  It is also thought that gap junctions play an important role in the 
coordination of contractions [19].  The conduction velocity of such contractions was 
found to be around 4-8 mm/sec.   
Characterization of flow through the lymph system is important in order to gain a 
better understanding of how the system responds to the various changes in physiological 
parameters such as interstitial fluid pressure, fluid volume, and interstitial fluid protein 
concentration.  There is an abundance of literature in this area of lymphatics.  Studies in 
gross lymph flow have been an ongoing project for over the past forty years [20].  
Original work did not concern itself with the mechanisms behind such flow, but rather 
5 
focused on obtaining quantitative measures of flow for the vessels of the lymphatic 
system in humans [9, 21-23].  The lymphatic contraction has also been investigated 
thoroughly and nomenclature for describing the contraction sequence has been 
developed [24].  However, no measurements have been reported of lymph velocities in 
the smaller (~ 100 µm), highly contractile lymphatic vessels.  In addition to this, 
contraction and flow have, for the most part, been studied independently of one another.  
The ability to simultaneously measure both contraction and fluid velocity would be 
highly beneficial in understanding exactly how the intrinsic pump helps to promote 
lymph flow.  This could also open the door for additional assessments of contraction in 
response to edema and various disease models.  Actual velocity measurements could be 
compared to ejection fraction estimates used previously [25], and could be used to assess 
the validity of such estimates.  Measurements of velocity could also be used to quantify 
some measure of efficiency for the valves ability to prevent backflow. 
There exists an overwhelming amount of literature that shows that the 
mechanical environment of various tissues plays an important role in the development 
and function of these tissues [26-35].   Usually the forces in this environment invoke a 
tissue response through some biochemical regulator.  With this hypothesis in mind, 
many investigators have studied the effects of various biochemical regulators on 
contraction frequency and amplitude [36-42], finding that one of the main factors shown 
to reduce the spontaneous transient depolarizations of the pacemaker activity in the 
lymph vessels is nitric oxide [25, 38, 42].  Others have shown the effects of various 
endothelial prostanoids on contractile activity [36, 40, 41, 43].  The main physical tissue 
6 
force whose effects on contractile function has been studied is pressure [2, 5, 24, 44].  
Originally it was thought that this was the primary physical mechanism through which 
the lymphatic pump could be inhibited or activated.  However, recently it has been 
shown that high flow produces an inhibition of the lymph pump when transmural 
pressure is kept constant [25, 45] (Figure 1.2).  Presumably this occurs due to wall shear 
stress.  This should come as no surprise because wall shear stress is one of the main 
mechanotransduction factors involved in vascular growth and remodeling [26-28, 30, 
36].  The main question that has arisen from the flow-induced studies of isolated 
lymphatic pump inhibition is whether or not the imposed flows are within a reasonable 
physiologic range.  Since the imposed flows were created by means of an axial pressure 
gradient, the actual velocities in these studies were not recorded, and since there is 
currently nothing in the literature reporting in vivo velocity ranges, comparisons between 
these isolated vessel observations and what actually might occur in vivo could not be 
made.   
It was also noted in one of the above mentioned studies that this flow inhibition 
phenomenon was dependent upon the region from where the vessel was isolated.  This 
dependence seems to indicate that shear stress might not only play a role in contractile 
function, but could also be involved in lymphatic development.  This hypothesis is 
further supported by the observation that interstitial flow plays a vital role in 
lymphangiogenesis [46-48].  However, conjectures can only be taken so far without data 
of actual velocity measurements in shear sensitive lymphatic vessels.   
7 
 
Figure 1.2:  Effects of imposed flow on contraction frequency and amplitude of a 
rat mesenteric lymphatic*. 
 
 
 
These velocity measurements need to be fairly detailed so that they can be 
combined with some mechanical modeling to calculate an estimation of wall shear stress.  
To perform these calculations, we need lymph velocity measurements for the entire 
                                                 
* Reprinted with permission from “Inhibition of the active lymph pump by flow in rat mesenteric 
lymphatics,” by Gashev et el., 2002, Journal of Physiology, 540, 1023-1037. Copyright 2002 by Blackwell 
Publishing Ltd. 
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contraction cycle and for the wide variety of contraction frequencies and strengths that 
have been observed in vivo.  These measurements could then open the door for a wide 
array of isolated vessel and cell culture experiments to further characterize the 
biomechanical response that has been observed. They could also be used to map out the 
signaling pathways through which wall sheer stress regulates contraction.  A 
comprehensive data set would also pave the way for a more detailed investigation of the 
fluid mechanics of lymphatic flow.  Understanding the finer details of the mechanical 
forces involved in the regulation of the active lymphatic pump could have profound 
implications on our knowledge of the lymphatics’ role in lipid transport and metabolism, 
interstitial fluid balance, and immune function.  This is the first step for developing new 
drugs and therapies for enhancing or inhibiting lymphatic growth, and for treating 
various lymphatic disorders such as lymphedema and lymphoma. 
9 
CHAPTER II 
DEVELOPMENT OF A HIGH SPEED IMAGING SYSTEM*
 
 In view of our desire to measure shear stress throughout the entire contraction 
cycle, we needed to develop an imaging modality that would be capable of measuring 
both the vessel diameter and the fluid velocity simultaneously.  Based on preliminary 
estimations the system needed to be able to measure velocities from 0.25 mm/sec to 10 
mm/sec, be direction sensitive, and be able to take continuous readings for at least 30 
seconds to ensure that multiple contractions cycles would be captured in a given data 
sequence.  Due to the fluids model that was chosen, which will be discussed in further 
detail in the next chapter, the system also needed to be able to measure the radial profile 
of the velocity distribution.  Since there are a wide variety of techniques that have been 
used in the past for velocity estimations of biological fluid flow (mostly blood flow), it is 
important to address the techniques and the various advantages and disadvantages of 
each in light of the qualifications that must be met for our specific application.  
 
2.1 Video Microscopy Analysis 
 Video microscopy analysis has long been the gold standard for imaging flow 
through micro vessels and vessel diameter [2, 17, 20, 24, 38, 40, 49-52].  The technology 
itself has existed for many decades, however recent developments in computing speed 
                                                 
* Reprinted with permission from “Measuring microlymphatic flow using fast video microscopy” by 
Dixon et el., 2005. Journal of Biomedical Optics, 10, 064016-1 to 064016-7. Copyright 2005 by 
International Society for Optical Engineering. 
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have allowed for more exhaustive image analysis algorithms to be developed.  In 
addition to this the development of high speed cameras have paved the way for greater 
temporal resolution [53, 54].   
 Almost all applications of such systems for lymph flow have used standard video 
camera capturing rates of 30 frames-per-second [17, 24, 25, 45, 55].  This has proved 
acceptable for measurements in contraction speed and average lymph flow, as the 
velocities that occur in such cases are not beyond the speed of the camera.  However, we 
hypothesize that velocities of local flow at certain sites are much higher than those that 
standard video systems are capable of measuring.  Our group at Texas A&M is 
investigating the use of a high-speed camera, with capabilities up to one million frames-
per-second, to measure these higher end velocities.  A similar system was used several 
years ago to investigate the effects of lipid absorption on lymphocyte transport [54].  
However, this group did not report lymphocyte velocities but rather employed a counting 
technique to quantify lymphocyte flux while recording vessel diameter before and after 
the ingestion of olive oil.  The advantage of such a technique is the ability for excellent 
resolution, both temporally and spatially.  Temporal resolution being that which is 
limited by the speed of the camera and the save time of the computer, and spatial 
resolution being that which is limited by the magnification of the microscope and 
resolution of the camera.  If the flow field is seeded with particles of some sort and the 
spatial resolution is high enough, one can get an estimation of the radial distribution of 
velocity across the vessel, one of the main features the velocity measurement system 
must have as mentioned previously.  The disadvantage of this method is that real-time 
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velocity measurements have yet to be obtained, as all of the calculations are done with 
post-processing techniques that can often be time consuming and tedious.  Also, the 
faster the frame-rate, the more data one has to analyze for a given duration of recording 
time.  Lastly, this technique is invasive and highly sensitive to motion artifact.  However, 
there are various in situ techniques that have been developed to minimize the effects of 
the invasive procedure on lymphatic contraction [17, 24], which will be discussed in 
further detail later on.  Overall this technique has proved to be adequate for gaining a 
physiological understanding of lymphatic function, particularly lymphatic contractile 
activity, although it has no clinical non-invasive applications.  
 
2.2 Fluorescent Techniques 
To overcome the poor contrast that is often inherent in biological imaging, 
investigators have developed various fluorescent techniques to be used in combination 
with some form of video microscopy.  Fluorescence microlymphography, a term used to 
describe the application of such techniques to the lymphatic vasculature, has been used 
to image the structure of lymphatic capillaries in various locations [23, 51, 56, 57].  
Since then, many groups have quantified flow using various fluorescent techniques [21-
23, 58, 59].  One fluorescent approach is to introduce into lymphatic capillaries 
fluorescein isothiocyanate (FITC)- labeled macromolucules such as dextran [8].  The 
advantage of such a technique is the accuracy of the average velocity measurements that 
can be achieved since the fluorescent signal detected is fairly strong.  The main 
disadvantage of such methods is that the introduction of foreign fluorescent particles into 
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the system could alter the flow pattern of what normally occurs physiologically, 
especially since most of the techniques involve a subcutaneous injection, which creates 
localized edema at the site of injection.  It is also difficult to measure the flow profile 
across the width of a vessel as current techniques concern themselves only with tracking 
the average speed of the fluid through the vessel and not the velocity profile.   
 
2.3 Doppler Techniques 
Doppler methods have been used with microscopy to measure flow for over 
thirty years [60]. Doppler-based methods for blood flow applications measure the 
doppler shift of a scattered source signal propagating through tissue resulting from 
moving blood particles within the tissue volume.  This source signal can be photons [61-
63], ultrasound [64], or an MR signal [65].  This method has been shown to be effective 
in a number of clinical scenarios where micro-vascular flow assessments are needed [66, 
67] and has demonstrated some efficacy for the assessment of burn depth by measuring 
flow in the vascular bed at the site of the burn [68-71].   It has also been demonstrated 
for assessment of perfusion in skin flap procedures with limited success [72-74].  
However, doppler flow through lymph vessels has proved to be more difficult as the 
method is dependent on the present of particles flowing through the system.  In most 
lymphatic vessels the presence of particles, particularly white blood cells, is much 
scarcer than the red blood cells in the blood.  In addition to this, lymph flow is much 
slower than that of blood as there is no “heart-like” pump driving the fluid at a constant 
rate through the system.  The flow patterns in lymphatic capillaries are also much more 
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complicated due to the presence of backflow which will be discussed in further detail in 
the next chapter.  Because of this, the measurement technique needs to be direction 
sensitive, which many doppler techniques are not.  These complications make a doppler 
approach much more difficult for the lymphatic system than for blood flow 
measurements.  However, to the knowledge of this author, one group has successfully 
used a doppler based approach to acquire direct measurements of lymph flow in the 
posterior lymph heart of toads [75].  In this specific case, many of the disadvantages 
discussed above do not occur here as the lymphatics system of most amphibians behaves 
more like the circulatory system with a pumping organ pushing flow through the vessels.  
No group has yet to successfully develop a doppler method to measure microlymphatic 
flow in mammals or humans.  Traditional doppler methods are designed to give a 
measure of the average flow velocity through the vessel, but do not have the necessary 
resolution to measure the radial profile across the vessel.  However, recent advances 
have been made to incorporate doppler imaging with optical coherence tomography 
(doppler OCT), to measure the radial velocity profile [67, 76-80].  As this technology 
advances, the speed and resolution limitations initially associated with it that would have 
made it difficult to apply to microlymphatics are being overcome.  However, there is still 
a necessity for flowing scatters in your probing volume, so this technique was dismissed 
in our initial attempt to find the most suitable technique.  We have found an interesting 
in situ method that will be presented in a few chapters that could improve this and make 
doppler OCT a very plausible (if not the preferable) technique for real time 
measurements flow patterns in contracting lymphatics.  Also, since OCT is an imaging 
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technique, the vessel diameter associated with a particular velocity reading can be 
measured provided one takes enough A-scans to traverse the entire diameter. 
 
2.4 Laser Speckle Techniques 
 Another optical technique that has had success in measuring fluid velocities of 
physiologic flow phenomenon is laser speckle [81-86].  The basic principle behind this 
technique is that motion in the imaging plane produces a blurring of the speckle pattern 
when imaging with a laser source.  This speckle pattern comes from constructive and 
destructive interference that occurs from using a coherent light source.  This blurring of 
the speckle pattern is proportional to the velocity and under proper calibration can be 
used to back out velocity measurements through evaluation of the image in the 
frequency domain.  We chose not to pursue this technique because it was thought that 
the motion artifact inherent to a contracting vessel would introduce to much noise into 
the system to be able to separate fluid motion from the speckle statistics.  In addition to 
this, speckle is never really a good thing in imaging but rather something one would like 
to avoid.  If we are able to take an image of the vessel itself, it would be much better 
than dealing with speckle.  There has been one group that has published several papers 
measuring lymphatic flow dynamics through a cross correlation speckle technique [87-
89].  The initial paper reported the ability to measure relative changes in lymphatic flow 
after the administration of a lymphotropic agent [88].  The other two papers present the 
same 15 sec sequence of data in which the speckle technique is used to measure 
lymphocyte velocity and then compared with a video microscopy technique [87, 89].  
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However the dynamic range of the measurement is much smaller than ours as no 
velocities were reported over 0.5 mm/sec.  Whether this limitation is due to the 
measurement capabilities of the physical system or to the animal preparation itself 
remains unclear.  The authors claim that they have the capabilities to measure velocities 
up to 10 mm/sec, so if this assertion is true then the data represented in the paper must be 
from a vessel preparation with fairly weak contractions.  In their most recent paper, the 
authors used Ringer’s solution in their preparation [55], which could cause the oncotic 
changes in the tissue and therefore inhibit lymphatic contractility. This is very likely the 
reason that the authors observed that only 50% of the lymphangions had phasic 
contractions (see Table 1 in [55]). It has also been demonstrated [17, 24, 25, 45] that rat 
mesenteric lymphatics exhibit much stronger contractile and pumping characteristics in 
situ as well in isolated vessels studies. Particularly Benoit et al. [24] reported that the 
amplitude of contractions of rat mesenteric lymphatics in situ was nearly two times 
higher than those reported by Galanzha et al. [55]. Moreover, the low lymph velocities 
observed by Fedosov et al. [87-89] very well could also be a result of the limitation of 
the speckle technique, as very large contractions would introduce more motion artifact 
and a fluctuating distance between the spot size and the random phase screen from 
which the flow is being measured. 
 
2.5 Techniques in Nuclear Medicine 
 X-ray imaging has been a diagnostic imaging tool for over a century - used to 
image bone structure.  More recently, radioactive imaging has been used to measure 
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flow by injecting particles such as technetium-99m-labelled polyclonal immunoglobulin 
and tracing them as they flow through the vessels [90].  The return signals are generally 
stronger than those using fluorescence and can therefore penetrate through thicker tissue, 
but are more invasive than fluorescent techniques since the injected particles can 
potentially be more harmful.  The initial cost to set such a system up is also much more 
expensive than both fluorescent techniques and video microscopy.  As in the fluorescent 
technique, you run the risk of the foreign particles you are introducing into the system 
interfering or altering the flow patterns that occur physiologically by creating some sort 
of unnatural edemous situation.  Other groups use various approaches (e.g. functional 
MRI) with contrast agents to measure lymph flow [91, 92].  These methods have shown 
great potential for evaluating chronic lymph disorders due to edema, but suffer speed 
limitations which make video microscopy techniques better for measurements of 
temporal shear and flow profiles.  
 
2.6 Materials and Methods 
 After evaluating the above mentioned techniques available for measuring 
biological fluid flow, it was decided that high speed video microscopy was the technique 
best suited for our application because of its ability to simultaneously measure vessel 
diameter and particle velocity.  High frame rates have enabled us to extend the detection 
capabilities of the velocity measurements without having to reduce magnification and 
compromise the spatial resolution.  Since we are able to use high magnifications, we can 
actually measure the radial location of a moving particle and thus take this into 
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consideration when developing a model for estimating wall shear stress.  Therefore this 
technique met all of the minimum criteria needed to perform our given experiments.  
The main drawback of this method, as we soon came to realize, was the large amount of 
post-processing required to extract the relevant information from the images. 
 
2.6.1 Hardware set-up and system specifications 
Initially it was uncertain as to how fast the camera (Dalstar64K1M, 1M fps 
245x245, CCD camera) needed to record images since it has capabilities up to 1 million 
frames per second.  This ultra high speed is possible by masking a 1024 x 1024 imager 
so that only 1 in 17 frames are exposed at a time, resulting in a 245 x 245 pixel image.  
The 17 frames are captured by shifting exposed pixels into the masked area.  Figure 2.1 
below shows the layout of the 1024 x 1024 image with each of its sub frames labeled.  
After capturing and saving this large image, it can later be decoded into its 17 smaller 
images by following the pattern shown in Figure 2.1.  In order to save the images at a 
rate fast enough to keep pace with the camera, the images were dumped into an allocated 
buffer of RAM (approximately 1 GB).  Once the RAM was full, the recording had to be 
stopped so that the images could be stored onto the hard drive.  The allocation of RAM 
available for this allowed us to capture 6528 total images before the buffer became full.  
A tradeoff exists between the speed of the camera and the length of continuous imaging 
that can be achieved.  Using prior knowledge from previous studies of lymph wall 
contractions done by our group [17], it was determined that the image sequences needed 
to be at least 15 seconds to capture several contraction cycles.   
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Figure 2.1:  Layout of the 1024 x 1024 imager and masking patterns to achieve 17 image 
frames at high frame rates within one large image. 
 
 
 
The camera speed was maximized while keeping the duration of the recording 
time to 30 seconds by saturating the 17th image in each image set.  Within one set of 17 
images, the first 16 images were captured with a 2 ms integration time per image (500 
frames per second).  The seventeenth image was saturated by increasing the integration 
time of the camera to 8 ms to extend the duration of the sequence given the limitation of 
RAM.  This resulted in a total time of 62 ms between each set of images (16 * 2 ms + 8 
ms + 22 ms memory transfer time).  This allowed for the measurement of velocities, in 
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theory, of up to up to seventeen times faster than the capabilities of previous imaging 
systems used to measure lymph velocities while still maintaining the necessary dynamic 
range of 30 seconds to image several complete contraction cycles.  These imaging 
parameters were set with a software interface available through Epix (XCAP-Std. V2.2, 
Buffalo Grove, IL).  Lymphatic wall measurements were recorded at the beginning of 
every set of 17 images.  This allowed us to measure wall contractions using a frame rate 
of 16 fps, a speed half of standard 30 fps cameras and sufficient to measure wall velocity 
throughout the phases of the contractile cycle. 
 
2.6.2 Manual image analysis protocol 
Each sequence of images had to be analyzed and processed to extract out the 
desired parameters: the velocity of the contractions in the lymphatic wall, the velocity of 
luminal lymphocytes, the diameter of the vessel, and the radial location of the 
lymphocytes with respect to the centerline.  We used a three point method to measure 
the luminal diameter and provide a reference to calculate the distance of each 
lymphocyte from the center of the vessel (Figure 2.2).  The diameter of the vessel wall 
(W) and distance from the centerline (D) are calculated using equations (1) and (2), 
given the variables as defined in Figure 2.2.  
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Figure 2.2: An image of a microlymphatic vessel with the measured wall coordinates 
(WB0 B, WB1 B, and WB2 B) and a lymphocyte at location (L(x,y)).  The field of view is roughly 
250 x 250 µm. 
 
 
 
 In the figure, 210 ,, WWW  are the three (x,y)-coordinates chosen along the wall of 
the vessel (Figure 2.2), while L  is the (x,y)-coordinate of a given lymphocyte (Figure 
2.2). Given this geometry, the vessel luminal diameter can be calculated as: 
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The velocities of the lymphocytes (VBL B) were measured by tracking the coordinates of the 
lymphocyte over a sequence of images using the following equation: 
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in which ),(
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yxLt  is the position of some given lymphocyte at time 0t .  The 
value, ),(
0
yxL tt ∆+ , is the position of the same lymphocyte at some time t∆  past 0t , and 
t∆  is the time interval between images. 
 
 The velocity of the wall contractions (VBWB) were calculated by the following 
equation: 
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in which
0t
W is the diameter of the vessel at time 0t .  Similarly, ttW ∆+0 is the diameter of 
the vessel at some time t∆  past 0t , and t∆  is the time interval between images. 
 
2.6.3 In vitro calibration 
Calibration experiments were conducted in order to quantify the ability of the 
system to measure velocities at high frame rates using the capturing method described 
above.  Two separate experiments were run: one to assess the sensitivity and accuracy of 
the velocity measurements, and another to determine the system’s ability to estimate the 
velocity and radial position of particles moving through a tube of similar diameter to the 
microlymphatics.  For the first set of experiments a wheel was used that rotated at 
various revolutions per minute and was positioned under the microscope for imaging.  
The wheel consisted of a motor-driven rotating disc with markings on it at a fixed radial 
distance as shown in Figure 2.3.  
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Figure 2.3:  Illustration of motor driven rotating disk.  Different motor speeds and radial 
markings correspond to various linear velocities. 
 
 
 
 Image sequences were recorded with the high-speed video camera 
(Dalstar64K1M, 1M fps 245x245, CCD camera) at a fixed radial distance (28.5 mm) on 
the wheel while varying the angular velocity so that a range of velocities could be 
measured that would be similar to those that were expected to occur physiologically (up 
to 15 mm/sec).  Multiple measurements were taken while maintaining a constant speed 
in order to quantify the sensitivity of such measurements. 
For the second set of experiments, we designed a physical model that simulated 
the sizes and arrangements of lymphocytes flowing through a microlymphatic using a 
suspension of microspheres that was passed through a glass capillary tube. A solution of 
sodium chloride was prepared that matched the specific gravity of the microspheres used 
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to simulate the white blood cells.  The saline solution also served to dilute the 7.12 µm-
diameter microspheres to a concentration of about 5·10P5 P microspheres/ml approximating 
the size and count of lymphocytes.  A glass capillary tube was heated and pulled out to a 
diameter of 140 µm, equivalent to the diastolic diameters of the lymphatic vessels we are 
studying.  These values were chosen to mimic the dimensions that occur in the 
microlymphatics being measured in-situ as closely as possible.  The fluid was passed 
through the tubing by applying a constant pressure with a level pressure head that could 
be moved up and down to control pressure.  The outflow resistance was set to yield 
velocities that are similar to those measured in situ (Figure 2.4).  The tubing was 
magnified using the same microscope optics used to record the lymphatic vessels. The 
images were recorded at a frame rate of 500 frames per second.  Velocity measurements 
were made at fixed moments in time (25 ms) for a range of flow rates (15-250 µl/hr).  
The actual flow rate was measured by using a bubble tracking technique [93] and 
compared to the flow rates calculated from the images. 
 
25 
 
Figure 2.4: In vitro flow sham used to calibrate system.  The pressure could be adjusted 
by changing the height of the water level.  The outflow resistance was set to center the 
velocity values in a physiologically relevant range. 
 
 
 
2.6.4 In situ animal protocol 
Three male Sprague-Dawley rats weighing 180-220 grams were used for these 
initial experiments. The rats were housed in an environmentally-controlled, American 
Association for Accreditation of Laboratory Animal Care-approved vivarium. Each 
animal was fasted for 12-15 hours before the experiments, while water was available ad 
libitum. Each rat was anesthetized with an intramuscular injection of Fentanyl-
Droperidol (0.3 ml/kg) and Diazepam (2.5 mg/kg). Supplemental doses of the anesthetic 
were given as needed. An abdominal incision was made to gain access to the mesenteric 
lymphatic vessels (Figure 2.5).  
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Mesentery 
 
Figure 2.5:  A loop of the small intestine pulled out to show the mesentery.  Lymphatic 
vessels (too small to be visible in this picture) are dispersed throughout the mesentery. 
 
 
 
A loop of the small intestine was exteriorized through the incision and gently 
positioned over a semicircular viewing pedestal on a Plexiglas preparation board capable 
of maintaining temperature and perfusing the vessel with a heated buffered solution 
(Figure 2.5). A lymphatic vessel was centered over an optical window in the preparation 
board. The exteriorized tissue was perfused with a phosphate buffered solution 
supplemented with HEPES (10mM) and 1% bovine serum albumin (Appendix II). The 
solution was pre-warmed to 38°C, and the pH adjusted to 7.4. The temperature of the 
exteriorized tissue and the animal's core were maintained at 36-38°C. The preparation 
board was placed on the stage of an intravital microscope (Zeiss), and the lymphatic 
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vessel was observed at a magnification of 100X-200X using an 80 mm projective lens, a 
10X water immersion objective, and a variable magnification intermediate lens (Figure 
2.6). The depth of field for this optic setup was approximately 14 µm. All the 
experiments were digitized with the high-speed video camera (Dalstar64K1M, 1M fps 
245x245, CCD camera) using the capturing technique described previously. 
 
   
 
Figure 2.6: System set-up for the in situ preparation.  The blue tube in figure passes 
APSS solution heated to 37° C. 
 
 
 
After imaging and recording the specimen, the image sequences were loaded for 
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analysis in Epix, an image analysis software package, using the three point measuring 
method described in the Theory section.  To record the wall measurements, a sequence 
of images were loaded through a program written in Matlab and three coordinates were 
selected with a cursor along the wall, as shown in Figure 2.2. This was done on sets of 
51 images for the entire sequence of 6258 images.  This ensured that the luminal 
diameter was being measure at the same location for the entire recording sequence.  
These coordinates were then imported into a program to make all of the necessary 
calculations.  Lymphocytes were tracked manually by recording the location of the 
coordinates of the lymphocyte.  An arbitrary lymphocyte within the field of view and 
depth of focus was chosen and that particle was tracked for 24 ms. Software was 
developed to import these coordinates and calculate the lymphocyte velocity, the 
distance of the particle from the centerline, and the volume flow rate (Appendix III).  
 
2.7 Results and Discussion 
 Since there are currently no other developed methodologies for measuring flow 
in contracting mesenteric lymphatics, we had to verify that our system was working on 
known values of velocity.  For the initial set of experiments we used a calibration wheel 
that was designed for calibrating a laser doppler system.  This proved to work quite well 
however we wanted to test the frame rates and magnifications we intended to use so we 
needed to replicate the physical parameters we would encounter in situ as closely as we 
could in vitro.  This led to the second set of calibration experiments.  Once the system 
was verified to be working correctly and the correct imaging speeds were chosen, we 
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conducted our in situ experiments. 
 
2.7.1 In vitro calibration 
Calibration experiments were conducted to ensure the accuracy of the camera 
timing and our velocity estimation procedure.  The calibration wheel was imaged at ten 
different velocities three times each and the velocities were calculated from the images 
and compared with the actual velocity of the wheel to test for system accuracy and 
sensitivity.  Figure 2.7 shows the actual versus measured velocities for all measurements 
(R2 = 0.999).  The system showed accuracy, with less than 2% error when compared to 
actual velocities, and a sensitivity that yielded an average standard deviation of ~0.17 
mm/sec for multiple measurements at a given velocity.  
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Figure 2.7: Actual vs. Measured velocities of in vitro calibration wheel with error bars. 
 
 
  
For the second set of calibration experiments, images were recorded while 
flowing fluid and microspheres through a synthetic vessel.  Velocities and the distance 
of the particles from the centerline were measured five different times throughout the 
sequence of flow for eight different flow rates.  Figure 2.8 shows the actual vs. average 
predicted flow rates for each of the eight measurements along with error bars (R2=0.999).  
Since the Reynolds number is very small (< 5), the volume flow rate could be calculated 
from the particle’s velocity and position given by Equation 2.5, which is a derived from 
Navier-Stokes for laminar flow through a tube (Q  = volume flow rate, rV = velocity of 
particle measured at some distance r  from the center, r = vessel radius).   
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This approximation resulted in an average error of 5.7% with a maximum error of 10.6%.  
This is more than likely due to the depth of field covering more than just the center of 
the vessel, resulting in error in the distance from the centerline measurements.  However, 
it was within acceptable limits to make reasonable estimations of in-situ flow rates. 
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Figure 2.8: Actual vs. Measured volume flow rates of microspheres flowing through 140 
µm glass tube. 
 
 
 
2.7.2 In-situ experiments 
Preliminary results for several contractions for three different rats have shown 
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the viability of this system to measure the velocity in the microlymphatic vessel of the 
rat while simultaneously recording the diameter of the vessel (Figures 2.9, 2.10, 2.11). 
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Figure 2.9: Vessel lumen diameter (mm) and lymphocyte velocity (mm/sec) for a 10 
second interval from first data set. 
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Figure 2.10: Vessel lumen diameter (mm) and lymphocyte velocity (mm/sec) for a 10 
second interval from second data set. 
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Figure 2.11: Vessel lumen diameter (mm) and lymphocyte velocity (mm/sec) for a 10 
second interval from third data set. 
 
 
  
Lymphocytes velocities ranged from -1 mm/sec to 7 mm/sec.  As can be seen by 
the three figures, the pattern and dynamic range of the diameters and the contraction 
frequencies varied from rat to rat.  Quantitative measurements of fluid velocities in the 
microlymphatics were recorded through the entire contraction cycle and fast video 
microscopy was used to measure velocities greater than 1 mm/sec for the first time.  As 
expected the velocity of the lymph fluid fluctuates in a cyclical pattern at the same 
frequency as the wall contractions with about a 90 degree phase difference.  The range 
of values measured for the lymphocyte velocities is much larger than previous systems 
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were capable of measuring using standard video microscopy.  For example, the typical 
field of view when applying the necessary magnification to these vessels is 250 x 250 
µm.  In order to track a particle one must measure that particle’s location at two different 
times.  This means that the particle can travel no further than 125 µm to ensure that the 
particle is captured twice before it leaves the field of view.  Therefore the maximum 
velocity a 30 frame per second camera could theoretically measure is 3.75 mm/sec 
(Velocity = distance/time = 125 µm/.033 s).  This is under an ideal scenario in which one 
could resolve the 125 µm “streak” that would occur as a result of the moving particle 
when imaging at 30 fps (assuming that you are not electronically shuttering).  This is 
illustrated by the images shown in Figures 2.12, 2.13, and 2.14.  These images were 
taken during the peak velocity measurement at time t=6.08 sec from Figure 2.9, which is 
during a peak velocity measurement of 5.8 mm/sec (larger than the 3.75 mm/sec limit).  
As seen by comparing Figures 2.12 and 2.13, which occur 2 ms apart, both particles 
appear in the field of view.  However, in Figure 2.14, taken 33 ms after Figure 2.12, 
neither lymphocyte is in the field of view.  It should be noted that each image has been 
subtracted from the image immediately following it in order to remove the background 
and enhance objects in motion.  Coordinates of the lymphocyte are also shown to 
illustrate the displacement of the lymphocyte from Figure 2.12 to Figure 2.13.  In 
conclusion, a conventional 30 fps imaging system is too slow given the velocities that 
we have measured in situ.   
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Figure 2.12: In situ image taken during 5.8 mm/sec fluid flow at time t = 0.  The 
coordinates correspond to the lower lymphocyte. 
 
 
 
 
Figure 2.13:  In situ image taken at time t = 2 ms after Figure 2.12.  The lymphocyte has 
moved 12 pixels.  
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Figure 2.14:  In situ image taken at time t = 33 ms after Figure 2.12.  Neither of the 
original lymphocytes is present in the image, however new ones have appeared. 
 
 
 
The maximum contractions observed in the microlymphatics of rats can be 60% 
of the vessel diameter, with average contractions being approximately 40-50% of the 
vessel diameter [17].  In this particular set of rats the contractions were about 40% of the 
maximum diameter.  This would lead one to believe that in vessels with even larger 
contractions, the maximum velocities observed would be even greater than the 7 mm/sec 
observed in this case, further emphasizing the need for a fast imaging system.  Figure 
2.15, shows the estimated volume flow rate from the data sets shown in Figure 2.9.  
Similar plots can be generated from our measurements shown in Figures 2.10 and 2.11. 
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Figure 2.15: Estimation of volume flow rates (µl/hr) from velocity data in Figure 2.9. 
 
 
 
Almost all applications of video microscopy systems for lymph flow have been 
captured with a standard video camera at a rate of 30 frames-per-second.  This has 
proved acceptable for measurements in contraction speed and average lymph flow, as the 
velocities that occur in such cases are not beyond the speed of the camera (less than 1 
mm/sec for microlymphatic flow given a magnification of around 100-200X). However, 
our group observed in initial experiments highly blurred particles during contractions 
that indicated that velocities of local flow during the phasic contractions are much higher 
than those that current video systems are capable of measuring.  For example, a particle 
moving at 7 mm/sec, if imaged with a conventional video microscopy system, would in 
theory be a blurred streak of about 250 µm in length. The problem is that the contrast 
between white blood cells and the lymph media is so poor given the complex in situ 
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image that the length of this streak cannot be measured, or even seen is some cases, and 
the velocity cannot be deduced.  Therefore, we pursued the use of a high-speed camera, 
using capture rates of up to five hundred frames-per-second, to measure these higher end 
velocities.    
 
2.8 Concluding Remarks 
There are currently a wide variety of imaging methods available for measuring 
lymph flow, each with their own advantages and disadvantages.  With the recent 
developments in camera speed and the constant improvements in computer performance, 
some of the limitations that existed in the past for lymphatic imaging were shown to be 
removed in this set of data.  The in situ data presented here corresponds to three 
segments of 10 seconds of continuous contractions in three different rats in order to 
show the feasibility of the system to accurately measure the higher end velocities that 
occur as well as to provide some verifiable data that such velocities exist.  Through the 
unique image acquisition process presented in this chapter, adequate data was collected 
for the first time to measure fluid velocity throughout the entire contraction cycle while 
maximizing the hardware resources currently available for acquisition.  Initial studies 
have shown velocities up to 7 mm/sec, which appear to occur immediately following the 
onset of vessel contraction. The post processing methods developed have been sufficient 
to measure the velocity, diameter, and distance of the lymphocyte from the centerline.   
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CHAPTER III 
CHARACTERIZATION OF THE ACTIVE LYMPH PUMP IN RAT MESENTERIC 
LYMPHATICS 
 
After developing a system, which was verified to have the necessary dynamic range and 
accuracy to measure lymphocyte velocities throughout the entire contraction sequence, 
we then sought to repeat the experiment on numerous animals to get a better 
representation of the ranges of values that might occur in mesenteric lymphatics under 
normal conditions.  Subsequently, we sought to characterize flow and contraction 
response to edemous conditions. 
 
3.1 Fluid Dynamics Theory 
 In order to estimate wall shear stress, a model was developed which would 
accurately reflect the fluid dynamics we were observing in situ and give us reasonable 
estimates of wall shear stress.  To do this we started with Navier-Stokes equations for 
flow through a cylindrical tube: 
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 In choosing these equations as a starting point, we are already making some 
assumptions to simplify the problem.  Namely, we are assuming axisymmetric flow of a 
Newtonian fluid through a cylindrical tube.  This is reasonable since most lymphagion 
have a cylindrical geometry and the contraction of an individual lymphangion is not 
really peristaltic, but rather the entire segment contracts at roughly the same time [17].  
This set of equations is still fairly difficult to solve.  To reduce this system down, we 
started by introducing some terms that would allow us to non-dimensionalize this system 
and eliminate negligible terms: 
 
∫= La dzt tzaLV 0
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∫ ∫= 2
0 02
),(1
T L
m dzdttzaLT
a :  mean radius   (3.3) 
=pV  average velocity that would result from steady z
p
δ
δ  at ma  
=L  distance between lymph valves 
ma
rr =*  Lzz =*  tt 2* ω=  arr V
VV =*  
p
z
z V
VV =*  
mP
pp =*  
  
 Each of these terms is a parameter that we can actually measure from our 
imaging system and get a range of values that occur physiologically.  After making these 
substitutions into the Navier-Stokes equations, we reduced the equations and dropped 
the star notation for convenience, yielding: 
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 From these equations it can be seen that essentially we have a term similar to the 
Reynolds number (
mpaVρ
µ ) and a Strouhal number (
p
m
V
a2ω ) which commonly occur in 
problems in fluid dynamics.  We measured each of these parameters with our imaging 
system and can report the reasonable ranges of each that occur in vivo (Table 3.1).   
We know that 12
2
<<
L
am  and 1<<
L
am  since the distance between valves is much larger 
than the vessel radius, so we have 
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Table 3.1: Ranges of coefficient values that appear in the non-dimensionalized Navier-
Stokes equations 3.4(a-c) along with their average values.  All values were measured 
from the entire data set of seven rats. 
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will dominate.  In Eq (3.5c), if we compare the terms 
mp aVρ
µ , 
p
a
V
V , and 
p
m
V
a2ω , the 
Reynolds term is almost always going to be much larger than the other two, so the 
Reynolds term will again dominate.  This leaves us with: 
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 The final assumption that can be made is that for most of the contraction cycle 
the velocity of fluid is much greater than the velocity of the vessel wall.  This allows us 
to ignore the terms with 
p
a
V
V
, thus removing equations 3.6a and 3.6b from the system and 
leaving us with Eq. 3.6c from which, though integration and application of the no slip 
boundary condition, we derive Poiseuille flow: 
     )'(
4
1)'( 22 rr
dz
dprv −−= ρν     (3.7) 
This simplification allows us to estimate wall shear stress from the parameters measured 
through our video microscopy system described in the methods section as the following: 
               
r
Vρντ 4=      (3.8) 
where,  
=τ wall shear stress 
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=ρ fluid density 
=ν kinematic viscosity 
=V spatially averaged velocity 
=r radius of the wall 
 
3.2 Materials and Methods 
 We used the same in-situ preparation described previously in Section 2.6.4.  This 
procedure was conducted on a total of 10 animals.  For each animal we recorded 6 
sequences of lymphatic contractile activity for 30 seconds.  Images were recorded using 
the high speed camera with the same hardware configuration and manual image analysis 
methods as described in Section 2.6.1 and Section 2.6.2 respectively.  Since it is 
necessary to have lymphocytes present in the vessel being imaged, some animal 
experiments did not prove to be useful for our analysis due to the rarity of lymphocytes 
that occurred.  Our final data set, which we used to characterize the flow response to 
lymphatic contraction, consisted of seven different rats. 
 
3.2.1 Volume loading protocol 
 We adapted a technique previously described by Benoit [24] to increase lymph 
flow.  The same anesthesia protocol described earlier was used to prepare the animal for 
surgery.  A tracheotomy was performed to facilitate respiration and the right femoral 
artery was cannulated for monitoring arterial pressure.  Experiments were terminated if 
the mean arterial pressure fell below 85 mmHg.  The right femoral vein was also 
46 
cannulated for intravenous fluid administration.  The same procedure for exposing the 
mesenteric lymphatics as described in Section 2.6.4 was used.  Lymph formation was 
increased by infusing saline at a rate of 0.2 ml/min/(100 g body wt), a value of plasma 
dilution that has been used by other investigators to increase lymph flow [94].  One 
minute sequences of images were taken for three different time periods using a high 
speed camera: a control before saline infusion, 5 minutes after infusion, and 10 minutes 
after infusion.  The integration time of the camera was set to 5 ms for the first 16 frames 
and 40 ms for the 17th frame.  This allowed us to extend the continuous recording time to 
1 minute.  Lymphatic contractility was measured using the correlation algorithm 
described in detail in Section 4.1.2.  Lymph velocity was tracked using the manual 
analysis method described in Section 2.6.2. 
 
3.3 Results and Discussion 
 In order to assess the effects of lymphatic contraction on lymph flow and velocity, 
we measured the wall contractions while simultaneously recording the fluid velocity for 
several contraction cycles.  The data was taken from 7 different rats, 15 different vessels, 
and corresponds to over 125 systolic contractions occurring collectively over a period of 
approximately 16 minutes. The mean diameter of the lymphatics measured in this study 
was 91 ± 9.0 µm. The average lymph flow measured in these vessels was 13.95 ± 5.27 
µl/hr with a mean velocity of  0.87 ± 0.18 mm/s. This resulted in an average wall shear 
stress of 0.64 ± 0.14 dynes/cm2, where 1 Pascal = 10 dynes/cm2. 
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3.3.1 Relationship between contractile sequence and fluid velocity 
 The pattern of lymphatic diameter and lymph flow was somewhat variable, 
presumably depending on the characteristics of the lymphatic contraction pattern (i.e. the 
direction of contraction propagation, the local versus distant contraction strength, the 
presence of multiple nearby pacemakers, etc.) A typical relationship between vessel 
contraction and the velocity pattern of the fluid in the vessel is shown in Figure 3.1.  
While the frequency, magnitude, and periodicity of the contraction cycle varies in the 
vessels, the relationship between the lymph velocity and vessel contraction remains 
similar.   
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Figure 3.1: Typical relationship between fluid velocity (mm/sec) and wall diameter (mm) 
of a mesenteric lymphatic vessel for several contraction cycles. 
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 The maximum orthograde lymph velocity typically occurs near or during the 
systolic peak of the contraction cycle while the maximum retrograde velocity occurs 
during the diastolic phase.  In order to obtain a more thorough analysis of this 
relationship, we calculated the time interval between the orthograde velocity peaks and 
the systolic diameter peaks (minimum) shown as T0 in Figure 3.2.  
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Figure 3.2:  Figure showing how the parameters T0 and Tw were calculated.  The ‘---’ 
represents the velocity pattern of tracked lymphocytes and the solid line represents a 
diameter tracing.  T0 is essentially a measure of phase difference while Tw is the period 
of the contraction cycle. 
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 We then normalized this to the period of the contraction cycle (the distance 
between systolic peaks, Tw.  The sign convention we used was negative T0 when the 
orthograde velocity peak occurred before the systolic diameter peak and positive when it 
occured after.  We performed the same comparison with the maximum retrograde 
velocity peaks and the diastolic diameter peaks.  The maximum orthograde velocity 
peaks occurred 0.082Tw ± 0.029Tw after the systolic diameter minimum.  The maximum 
retrograde velocity peaks occurred -0.115Tw ± 0.023Tw before the diastolic diameter 
maximum.  From this analysis we can see that there is a slight phase delay in the 
response of the fluid flow to the contraction cycle.  Often the contractions are not quite 
as periodic as those shown in Figure 3.1.  When this occurs the correlation between the 
fluctuations in fluid velocity and the local contraction are not as well defined (Figure 
3.3).  
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Figure 3.3: Example of a contraction sequence that is irregular and contains periods of 
little to no contractile activity. 
 
 
 
 Common patterns were seen throughout the sample set when comparing fluid 
velocity with vessel contraction.  While the frequency and amplitude of contractions in 
mesenteric lymphatics is quite variable, the relationship between contraction and fluid 
velocity remains fairly consistent.  This can be seen through a comparison of Figure 3.1 
to Figure 3.3.  The vessel in Figure 3.1 has a consistent cyclical pattern of contraction 
with a frequency of 0.4 cycles/sec, while the vessel in Figure 3.3 has a more complicated 
diameter behavior, with contractions of different strengths occurring over a 20 second 
interval.  However, it should be noted that whenever a strong contraction at the site of 
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observation occurs in Figure 3.3 (t = 4 sec, 17 sec, and 19 sec), that a definite peak in 
velocity occurs as well.  During the interval when there are no strong contractions 
(between t = 7 sec and 16 sec) one can still see fluctuations in the fluid velocity.  These 
fluctuations are most likely due to the contractive or compressive effects of adjacent 
lymphangions (both upstream and downstream of the imaging site). 
 In general, a reversal of flow occurs during a brief portion of diastole (Figure 
3.1).  Presumably this flow reversal corresponds to the valve closure up-stream.  As fluid 
flows in the reverse direction it pushes the valves shut, thus limiting the amount of fluid 
that flows back into the previous lymphangion and promoting a net effect of forward 
flow.  The velocity of this reversal usually peaks out at approximately -1 mm/sec, 
although there were one or two vessels that had peak retrograde velocities as high as -3 
mm/sec.   
 To characterize the relationship between volume and velocity we normalized 
several contractions from different rats and plotted volume versus velocity over one 
contraction (Figure 3.4).  Point A corresponds to the maximum vessel diameter.  
Borrowing the terminology first used in describing cardiac function, this point 
corresponds to the very end of diastole and the beginning of systole.  If this trace is 
followed up to point B, it can be seen that as the vessel volume decreases, the fluid 
velocity increases.  Point B is the minimum vessel diameter or the systolic peak.  The 
rapid increase in velocity before and after point B might be due to the expansion of a 
downstream lymphangion, since these contractions have been previously shown to 
propagate [17].  However, we cannot be certain of this since we did not have a large 
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enough field of view to monitor adjacent lymphangion in these studies.  The point of 
maximum velocity, point C, occurs after the systolic peak at a slightly larger vessel 
volume.  This agrees with the slight phase delay we reported above and is visible in 
Figure 3.1 as well.  The velocity begins to decrease as the vessel expands until it reaches 
its minimum at point D.  The velocity here is actually in the reverse direction, which we 
have termed the maximum retrograde velocity.  The most interesting portion of this 
figure is the interval from point D back to point A.  The velocity of the fluid actually 
increases back to zero as the vessel continues to expand.  This provides additional 
support to the theory that the reverse velocity helps to close the valves and prevent any 
further back flow into the downstream lymphangion.  At point A, the diastolic expansion 
ends and the cycle starts all over again.   
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Figure 3.4: The relationship between normalized vessel volume and normalized fluid 
velocity. Labeled points correspond to: A) Peak diastolic diameter and beginning of 
systolic contraction, B) Systolic diameter, C) Peak orthograde velocity, D) Peak 
retrograde velocity. 
 
 
 
It should be acknowledged that this figure was created from averaging four 
different contraction sequences.  The selection of data was limited to segments where the 
contraction frequency was fairly constant.  All units have been normalized due to the 
variations in size and average velocity from rat to rat. 
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3.3.2 Wall shear stress and volume flow rate estimates 
 Within our data set for a given moment in time, we measured the velocity of an 
arbitrary lymphocyte in the vessel, the distance of that cell from the vessel’s centerline, 
and the vessel diameter.  Using these parameters and our model of Pouiselle flow, we 
estimated the volume flow rate and wall shear stress throughout every contraction cycle.  
The calculations for the sequence represented in Figure 3.1 are shown in Figures 3.5 and 
Figure 3.6.  The volume flow rate and wall shear stress plots look very similar to the 
velocity tracings due to the fact that all three terms are directly proportional to one 
another.  For this particular contraction cycle, one can see that the volume flow rate 
reaches a value around 220 µl/hr during the peak of systole and averages 20 µl/hr.  The 
peak wall shear stress approaches 9 dynes/cmP2 P, while the average wall shear stress is 
0.82 dynes/cmP2 P 
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Figure 3.5: Estimation of the volume flow rate (µl/hr) for the same data set represented 
in Figure 3.1. 
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Figure 3.6: Estimation of wall shear stress (dynes/cm^2) for the same data set 
represented in Figure 3.1. 
 
 
 
 We also calculated volume flow rates under the assumption that no retrograde 
flow occurs, only taking into account the displacement of fluid due to volume changes in 
the vessel.  To calculate this parameter we integrated the volume changes in the vessel 
during systole and assumed no fluid was pulled back into the vessel during diastole.  We 
refer to this parameter as the ejection flow rate.  For the data set referenced above the 
ejection flow rate was 34 µl/hr.  From the lymphocyte velocities, we calculated the 
percentage of flow that was in the forward direction (% orthograde) compared to the 
backwards direction (% retrograde) by integrating the velocity fluctuations.  For the data 
sequence in Figure 3.1, the percentages were 92% and 8% respectively. 
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 It is known that in addition to pressure, lymph flow, by means of wall shear 
stress, plays an important role in the coordination of wall contractions and lymph 
propagation.  This theory is supported by the study of the inhibition of the lymph pump 
due to flow under constant transmural pressure which was described earlier [25].  An 
important question that has arisen from this work is whether or not the velocities 
experimentally induced in the isolated vessels are physiologically relevant.  If one were 
able to report these velocities, and more importantly approximate the shear stresses that 
occur in vivo, it would not only validate these conclusions, but it would also open the 
door for future work in flow-induced endothelial release of vasoactive substrates in 
lymphatic vessels, which could potentially play an important role in both the regulation 
and the development of the microlymphatic network. 
 Our justification of Poiseuille flow through careful analysis of the Navier-Stokes 
equations proved to be quite useful, since the system we developed had the capability to 
measure all of the necessary parameters needed in the model (namely vessel diameter, 
lymphocyte velocity, and lymphocyte position from the vessel centerline).  However, we 
first needed to verify that such a model was a reasonable approximation for flow in 
contracting microlymphatics.  By deriving non-dimensional Navier-Stokes equations for 
axi-symmetric flow though a cylindrical tube, as shown in section 3.1, we introduced 
coefficients into the system of equations whose range of values could be measured from 
the data set (Table 3.1).  This allows us to know when the model is reasonable and under 
what periods of the contraction cycle it could break down.  The main limitation of the 
final simplification is that the estimate is only reasonable for periods of flow in which 
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the magnitude of the fluid velocity is much greater than the magnitude of the wall 
velocity.  Fortunately, this is true for most of the contraction cycle and really only breaks 
down during the period of flow reversal when the fluid velocity is near zero.  Figure 3.7 
was taken from the same data set as Figure 3.1.  Note that while the assumption that 
Va<<Vp is true for most of the contraction cycle (i.e. those points that on the graph that 
are close to zero), there are periods in which the assumption breaks down and our 
method of calculating shear stress might break down as well.  Because of the model used, 
the temporal cycle of wall shear stress has a pattern similar to the fluid velocity with the 
maximum shear stress of around 8 dynes/cm2 occurring just after the systolic peak. 
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Figure 3.7:  Ratio of the wall velocity (Va) to the lymphocyte velocity (Vp) for the data 
represented in Figure 3.1.  
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 The other parameter that relies heavily on the assumption of Pouiselle flow is the 
volume flow rate.  The flow rate is not actually measured but is calculated when the 
position and velocity of a single lymphocyte are applied to the Pouiselle flow model.  
The proximity of the mean volume flow rate to the volume ejection estimation, along 
with the observation that the mean volume flow rate is well correlated with the vessel 
radius and contraction velocity, seem to support that Pouiselle flow is indeed a 
reasonable model for estimating the volume flow rate for the majority of the contraction 
cycle. 
 
3.3.3 Parameter averages for rat mesenteric lymphatics 
 Averages for the entire data set are summarized in Table 3.2.  These averages 
represent data taken from seven rats over twenty-six different intervals of 30 seconds of 
raw flow data.  Table 3.2 is an attempt to give a summary of the various phenomena 
observed throughout this study on each rat as well as to report overall averages.  The 
average vessel size used was around 90 µm in diameter which is a reasonable average 
for rat mesenteric lymphatics.  Maximum and average values for cell velocity, wall shear 
stress and the root mean squared (RMS) contraction velocity (an index of the strength 
and frequency of phasic contractions) are reported as a means of characterizing 
contractile activity.  In one animal, maximum shear values were found to be around 10 
dynes/cm2, while the average maximum value was found to be apporoximately 6 
dynes/cm2.  On average orthograde flow occurred 93% of the time.  A comparison of the 
measured volume flow rate with the proposed volume flow rate, calculated as the 
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ejection flow rate, shows that on average the actual volume flow rate is less than (~72%) 
the ejection flow rate. 
 
 
Table 3.2: Average values and mean standard errors of various parameters from 
seven different rats. 
  Rat 1 Rat 2 Rat 3 Rat 4 Rat 5 Rat 6 Rat 7 Average 
Avg Velocity, pV  
(mm/sec) 
0.35 1.01 1.51 1.02 1.15 0.43 0.55 0.87 ± 0.18
Avg Shear Stress, 
wτ  (dynes/cm^2) 0.33 0.69 0.84 0.72 1.21 0.30 0.37 0.64 ± 0.14
Avg Diameter, D  
(µm) 
77 92 125 112 66 97 70 91 ± 9.0 
Average Volume 
Flow Rate, Q  
(µl/hr) 
3.83 17.83 39.48 18.02 9.93 6.66 1.88 13.95 ± 5.27
Max Shear, maxwτ  
(dynes/cmP2 P) 
7.78 3.91 4.72 4.21 11.91 2.56 8.21 6.19 ± 1.33
Maximum 
Velocity, maxpV  
(mm/sec)  
2.24 5.32 7.54 6.76 8.98 3.98 4.91 5.68 ± 0.93
Minimum 
Velocity,  minpV  
(mm/sec) 
-0.70 -1.89 -1.99 -2.40 -0.64 -2.76 -1.19 -1.65 ± 0.34
RMS Contraction 
Velocity, armsV  
(µm/sec) 
22.94 52.70 69.53 51.77 27.86 39.40 38.19 43.2 ± 6.54
% Orthograde 98 97 94 89 98 82 90 92.5 ± 2.4 
% Retrograde 2 3 6 11 2 18 10 7.5 ± 2.4 
Ejection Flow 
(µl/hr) 7.31 21.54 43.87 29.17 7.09 18.74 8.24 19.42 ± 5.58
 
 
 Of particular interest is the relationship between the RMS contraction velocity, 
the average radius, and the average volume flow rate for each imaging sequence as 
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shown in Figure 3.8 and Figure 3.9.  From Figure 3.8 one can see that expressing the 
volume flow rate as a function of the square of the average vessel radius gives a 
correlation coefficient (R2) value of 0.6102.  If an additional variable, the RMS 
contraction velocity (an index of the strength of the phasic contractions), is introduced 
into the model the R2 value improves to 0.7994 (Figure 3.9).  In steady flow situations it 
is well known that the volume flow rate is directly proportional to the radius squared.  
However, in this case we have unsteady flow and thus the rate of contraction also plays a 
role in the promotion of flow. 
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Figure 3.8: Relationship between the radius^2 and the volume flow rate.  Data matched a 
linear fit with a correlation coefficient of 0.6102.  
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Figure 3.9: Relationship between the radius^2 multiplied by the RMS contraction 
velocity and the volume flow rate.  The linear correlation statistic was improved to 
0.7994. 
 
 
 
 Intuitively, it has long been thought that the intrinsic lymphatic pump plays a 
major role in the promotion of lymph flow through the lymphatic microcirculation [9].  
This hypothesis is further supported by the evidence provided from Figure 3.8 and 
Figure 3.9.  The results from Figure 3.8 should come as no surprise, since on average 
larger vessels are known to have larger volume flow rates (R2=0.6102).  This fit is 
improved (R2=0.7994) when we take into account that pumping activity might also play 
an important role in increasing the volume flow rate (Figure 3.9).  A larger RMS 
contraction velocity, which is essentially a measurement of the contractile activity of the 
vessel, does in fact increase the volume flow rate.  It should be noted however, that 
under conditions in which a large pressure gradient already exists to promote flow, 
vessel contraction would actually inhibit flow [25].  In contrast, under conditions in 
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which no such pressure gradient is present or is very small, the active pump of the 
lymphatic vessel plays an important role in the promotion of lymph flow as evidenced 
by the fact that as pumping activity increases, the overall volume flow rate increases as 
well.  Another way to investigate the effectiveness of the vessel contraction in promoting
lymphatic flow is to compare the measured volume flow rate with the estimated volume 
ejection, both shown in Table 3.2.  Since the estimated volume ejection was calculated 
with the assumption that all of the fluid displaced by the change in vessel volume would
be ejected in the forward direction, one would expect that the actual volume flow rate 
would be slightly less than this value assuming there are no other pressure gradients.  O
average this seems to be the case (13.95 µl/hr < 19.42 µl/hr).  The instances in which the 
actual volume flow rate is drastically smaller than the flow estimated from the ejection 
fraction may be an indication that the vessel is working against a pressure gradient 
upstream.  For the one case in which the volume flow rate is greater than the ejectio
flow rate (Rat 5), it is likely that the vessel is experiencing a pressure gradient that 
promotes flow independent of the local contractions. 
 A few comments should be made here in regar
 
 
n 
n 
ds to using the calculated 
e at 
e 
percentages of orthograde and retrograde flow shown in Table 3.2 as a means of 
characterizing valve efficiency.  For the most part, the valves were highly effectiv
preventing backflow into the upstream lymphangions; however, the effectiveness of th
valves in preventing retrograde flow was shown to vary.  For instance, the valves in Rat 
6 were the least effective in preventing retrograde flow as it occurred 18% of the time.  
The reasons for this may be because this particular vessel was working against an 
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unusual pressure gradient, the valves may have been less effective, or there were 
multiple pacemakers and unusual contraction patterns, although we can really only 
speculate as to the exact cause at this point. 
 The estimation of wall shear stress was the main motivation behind this study, 
 
ue to 
es up.  
due to the questioned relevance of the pressure gradients applied in the flow-inhibition 
study cited throughout this chapter. Our fluids model was used to calculate the wall 
shear stresses and velocities applied in an original paper by Gashev, et. el [25], since
only the axial pressure gradients were originally reported.  Two wall shear stress 
parameters were estimated: 1) the wall shear stress resulting from the fluid flow d
the imposed axial pressure gradient, and 2) the wall shear stress resulting from the vessel 
contraction using the ejection volume estimation approach (Figure 3.10).  As the 
transaxial pressure increases, the wall shear stress due to this pressure gradient go
The vessel appears to compensate for this by decreasing the frequency and amplitude of 
contraction and thus reducing the wall shear stress due to the phasic contraction.   
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Figure 3.10: Wall shear stress estimates (dynes/cm^2) due to the imposed axial pressure 
gradients and phasic contractions calculated using current fluids model with previously 
reported isolated vessel experiments and plotted as a function of transaxial pressure 
gradient (cm H2O). 
 
 
 
 This compensation seems to suggest that lymphatics have the capability of 
regulating wall shear stress, a capability of arterioles and venules that has been 
previously reported [27].  However, the average wall shear stresses that occur in the 
microlymphatics are significantly lower than those reported in the arterioles and venules 
[95] suggesting that the signaling mechanisms behind this shear stress dependent 
response in microlymphatics might be different or at least more sensitive than those that 
have been studied extensively in the microcirculation [27].  The wall shear stresses 
displayed in Figure 3.10 represent estimates using data from isolated lymphatic studies 
published previously and are in the same range as those that have now been observed 
and reported in situ, thus the magnitudes of imposed flows in the design of previous 
isolated lymphatic studies [25] appear physiologically relevant.  
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3.3.4 Lymphocyte flux data 
 Measuring the lymphocytes as markers of fluid flow provided another valuable 
piece of information regarding lymphatic function, an estimate of lymphocyte flux. 
Lymphatic vessels provide an important pathway in the trafficking of immune cells from 
the tissue spaces to the lymph nodes. Measurements of lymphocyte flux and density 
were taken for each of the seven rats represented here (Table 3.3).  As noted in the table, 
there is a lot of variability between the number of lymphocytes present in each animal.  
The average lymphocyte flux in these vessels was 990 ± 260 cells/min with an average 
lymphocyte density of 12,000 ± 5,200 cells/µl.  
 
 
Table 3.3: Values of lymphocyte density and lymphocyte flux for each of the seven rats 
represented in Table 3.2 
  
Lymphocyte Density 
(cells/µl) 
Lymphocyte flux 
(cells/min) 
Rat 1 2.20E+04 1.30E+03 
Rat 2 1.23E+04 2.03E+03 
Rat 3 3.26E+02 2.06E+02 
Rat 4 3.65E+03 1.11E+03 
Rat 5 2.00E+03 2.40E+02 
Rat 6 8.57E+03 9.37E+02 
Rat 7 3.55E+04 1.11E+03 
Average 1.20E+04 9.90E+02 
Standard Error 5.19E+03 2.57E+02 
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3.3.5 Volume loading experiments 
 To analyze the data from the volume loading experiments several different 
techniques were used.  Since this data was collected much later than the initial 
physiology data just presented, the correlation algorithm which will be discussed in 
detail in Chapter IV had already been developed and verified.  Therefore, the wall 
diameter was tracked using this method of post-processing; however, the number of 
lymphocytes available for tracking was very low in these experiments, especially after 
volume loading.  This lack of lymphocytes prevented us from being able to use the 
correlation program for measuring the velocity, since it is highly dependent on a large 
number of particles in the field of view.  Therefore, we used manual particle tracking as 
described earlier to measure the lymphocyte velocity.  Each measurement (Table 3.4) 
corresponds to a one minute sequence of analyzed data.  A total of 5 rats were tested (R1, 
R2, etc…) and flow sequences were recorded at three different time intervals: control 
before volume loading (C), five minutes after volume loading began (5), and ten minutes 
after volume loading began (10).  The average lymphocyte velocity in the table 
represents the mean velocity of all lymphocytes tracked (at least 200) during the one 
minute interval. 
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Table 3.4:  Changes in contractile dynamics and average lymphocyte velocities for 5 
different rats at 3 different time periods each: control, 5 minutes after loading began, 10 
minutes after loading began, X’s denote period where no measurement could be made 
due to rarity of lymphocytes. 
 
  
Avg 
Diam 
(µm) 
Max 
Diam 
(µm) 
Min 
Diam 
(µm) 
RMS 
CV 
(µm/s) 
Avg Lymp Vel 
(mm/sec) 
R1(C) 81.5 120.7 52.3 36.2 0.40 
R1(5) 94.8 111.7 60.4 33.8 0.50 
R1(10) 91.7 111.7 70.4 48.2 0.45 
        
R2(C) 87.8 97.6 58.3 23.0 0.11 
R2(5) 102.6 116.7 80.5 17.5 0.09 
R2(10) 81.0 108.6 65.4 29.7 0.07 
        
R3(C) 42.4 62.4 30.2 30.4 0.09 
R3(5) 59.3 76.4 44.3 43.0 0.25 
R3(10) 53.5 69.4 38.2 35.9 0.17 
        
R4(C) 56.1 63.4 38.2 24.7 0.07 
R4(5) 69.2 91.5 37.2 31.7 0.36 
R4(10) 66.5 84.5 52.3 39.4 X 
        
R5(C) 60.0 82.6 39.8 22.4 X 
R5(5) 67.5 95.5 41.8 34.5 X 
R5(10) 38.8 70.6 19.9 37.5 X 
 
 
 In order to be able to draw conclusions about the overall response of lymphatic 
flow and velocity to contraction, each data set had to be normalized to its control period 
to remove animal to animal variability (Table 3.5).  From the normalized data it can be 
seen that the average diameter increased five minutes after volume loading as compared 
with the control (1.22 ± 0.05).  After 10 minutes it seemed to return to its original state 
(1.03 ± 0.12) although it is hard to be certain since the standard error is so large.  
Maximum and minimum diameter increased 5 minutes after the control (1.19 ± 0.09 and 
1.20 ± 0.11 respectively).  RMS contraction velocity, which is a measure of contractile 
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activity, increased at 5 minutes and then again at 10 minutes after the control (1.19 ± 
0.16 and 1.41 ± 0.10 respectively).  Average lymph velocity also increases 5 minutes 
after control ( 2.61 ± 1.23).  Data is missing for the average lymph velocity from four 
runs of data due to the very low lymphocyte concentrations in those sequences.  In 
general lymphocyte density was found to diminish after volume loading. 
 
 
Table 3.5:  Data from Table 3.4 that has been normalized with the control period to 
remove animal to animal variability. 
   
Avg 
Diam 
(a.u.) 
Max 
Diam 
(a.u.) 
Min 
Diam 
(a.u.) 
RMS 
CV 
(a.u.) 
Avg 
Lymph 
Vel 
(a.u.) 
 R1(C) 1.00 1.00 1.00 1.00 1.00 
 R1(5) 1.16 0.93 1.15 0.93 1.23 
 R1(10) 1.13 0.93 1.35 1.33 1.11 
          
 R2(C) 1.00 1.00 1.00 1.00 1.00 
 R2(5) 1.17 1.20 1.38 0.76 0.82 
 R2(10) 0.92 1.11 1.12 1.29 0.63 
          
 R3(C) 1.00 1.00 1.00 1.00 1.00 
 R3(5) 1.40 1.23 1.47 1.41 2.88 
 R3(10) 1.26 1.11 1.27 1.18 2.00 
          
 R4(C) 1.00 1.00 1.00 1.00 1.00 
 R4(5) 1.24 1.44 0.97 1.28 5.52 
 R4(10) 1.19 1.33 1.37 1.60  X 
          
 R5(C) 1.00 1.00 1.00 1.00  X 
 R5(5) 1.13 1.16 1.05 1.54  X 
 R5(10) 0.65 0.86 0.50 1.67  X 
       
Mean (control)   1 1 1 1 1 
Mean (5 min)   1.22 1.19 1.20 1.19 2.61 
Mean (10 min)   1.03 1.07 1.12 1.41 1.25 
       
std error (control)   0 0 0 0 0 
std error (5 min)   0.05 0.09 0.11 0.16 1.23 
std error (10 min)   0.12 0.09 0.18 0.10 0.49 
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3.4 Concluding Remarks 
 Much work lies ahead of us if we desire to more fully understand the physical 
mechanisms and forces in place that both govern and influence lymphatic contractile 
regulation and lymphangiogenesis.  However, without more detailed measurements of 
the lymph velocities and shear stresses that occur in vivo, it is difficult to establish the 
significance of the observed in vitro effects, whether by means of cell culture or isolated 
vessel models.  The studies discussed here provide the measurements needed to establish 
the groundwork for the microlymphatic network, which should aid investigators in 
determining the necessary physical test conditions to create when investigating the 
specific signaling mechanisms and functional responses that these physical forces elicit. 
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CHAPTER IV 
CORRELATION METHOD FOR PROCESSING LYMPHATIC IMAGES 
 
 The recent development of a high speed imaging system to measure lymphatic 
flow and estimate wall shear stress has now opened up a new area of research in 
lymphatic microcirculation [96].  The main difficulty with this system is the tedious 
post-processing required to analyze the large amount of data produced by high speed 
imaging (500 fps).  To put this into perspective, the findings recently published by 
Dixon [97], which corresponded to data taken from 7 rats for a total of about 24 minutes 
or approximately 288,000 images, took over a year and a half to analyze.  Not only is 
this expensive in terms of man hours, it is also difficult to perform various other flow-
related studies when the results take so long to process.  Pre-packaged particle tracking 
software produced spurious results due to the inherent low contrast of the imaging site.  
Contrast could be improved through the injection of fluorescent tracers; however, that 
would be undesirable given the influences such injections could have on tissue 
homeostasis.  These limitations have led us to seek out an image analysis technique to 
calculate the fluid velocities automatically without having to introduce fluorescent 
tracers into the system. 
 Recently, Tsukada [53] reported on an image correlation method combined with 
a high speed imaging system that could measure the flow of erythrocytes in small 
capillaries (<50 µm in diameter).  This method relies on measuring the displacement of a 
particular red cell distribution pattern between image frames through the use of the 
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correlation function.  We have taken this method, adapted it, and integrated it into our 
high speed imaging system to simultaneously measure lymphatic flow and vessel 
diameter.  With this innovation, an image sequence that would normally take over a 
week to analyze manually can be processed automatically with a high degree of accuracy 
in less than 30 minutes. 
 
4.1 Materials and Methods 
 Since this correlation technique relies on the presence of particles to track their 
movement, only vessels with numerous lymphocytes were chosen to develop the 
algorithms for particle tracking.  Considering that we had taken a large set of images 
using the in situ procedure described previously, no additional animal preparations were 
initially done.  All code for the image correlation method was written in Matlab M-files 
and run in the command window. 
 
4.1.1 Measuring lymph flow velocity 
 One of the main difficulties of automated image analysis of lymphocyte flow in 
lymphatic vessels is the poor contrast inherent to the images (Figure 4.1).  In order to 
overcome this obstacle we took two sequential images separated by 2 ms and subtracted 
them from one another.  This subtraction enhanced pixels in motion, while canceling out 
the motionless background.  Given our sampling rate and magnification, the resulting 
image would only show particles moving greater than about 0.25 mm/sec, and would 
filter out the “motionless” background (motion less than 0.25 mm/sec).  In our previous 
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work, we measured the motion artifact from vessel drift and the velocity of wall 
contractions to usually be well under 0.25 mm/sec. 
 
 
Figure 4.1:  Image of a lymphatic vessel illustrating the poor contrast at the imaging site.  
There are actually several, 15 to be exact, lymphocytes present in this image, although 
they are very difficult to distinguish from the background unless you can see them move 
from frame to frame. 
 
 
 
The subtraction described above was repeated with another pair of images and 
the two resultant images were then processed through a low pass filter to remove high 
frequency noise due to pixel to pixel variations.  Each of these filtered images was then 
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used in the image correlation algorithm.  A total of four raw images were used to 
calculate the fluid velocity as shown by the following equations (4.1 – 4.3): 
 
      Picf = LPF(Pic1-Pic2)     (4.1) 
      Picg = LPF(Pic3-Pic4)    (4.2) 
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 In the above equations, Pic2 and Pic3 are separated by 4 ms, ),( yxfm  
corresponds to a given pixel within the window created in Picf, ),( yxgm  corresponds to 
a given pixel in Picg, f  is the mean of window mf , and g is the mean of window mg .  
LPF refers to the low pass filter used on the subtracted images.  The window in image 
Picf was fixed, while the window in Picg was scanned across the picture to find the 
location of maximum correlation.  The resultant window displacement, when combined 
with the known frame rate, gives a measure of fluid velocity (Figure 4.2).   
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Figure 4.2:  Illustration of the principle of the image correlation approach.  Each image 
is taken at the same location separated by a small time interval.  The displacement of the 
window corresponds to the movement of the fluid. 
 
 
 
The main limitation found in using this approach with lymphatic vessels is that 
the particle densities are much lower than those found in the blood.  Due to this 
limitation, we found that the best results were produced with a window size approaching 
at least half of the vessel diameter.  All analysis was done in Matlab after capturing 
images with a high speed camera. 
 
4.1.2 Measuring vessel diameter 
 The program was then modified to measure changes in vessel diameter.  The 
program first provides an image for the user to select the left and right vessel wall on the 
image.  The program then creates two reference windows around each of the selected 
locations.  The displacements of these windows are measured by finding the maximum 
correlation in a sequential image as governed by Equation 4.3.  From the coordinates of 
t∆ x∆
mf mg
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these two windows, the vessel diameter can be measured through a simple subtraction 
(Figure 4.3).  The displacement of the two windows averaged together gives information 
about motion artifact and overall image drift, which proves useful for improving the 
algorithm as described in the next section. 
W1 
 
W2 
Figure 4.3: Two reference windows are created around each of the vessel walls in the 
same vertical location.  Their displacements are tracked to measure changes in vessel 
diameter. 
 
 
 
4.1.3 Optimizing the image correlation algorithm 
 After initial analysis, several improvements were made to the code.  It was noted 
that the maximum correlation location was not always a good match and thus produced 
erroneous outliers in the velocity tracings.  To improve this, a measure of relative 
correlation was introduced into the method by taking the ratio of the peak correlation 
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value with the average of its surrounding values (Figure 4.4 and Figure 4.5).  As can be 
seen by visually comparing Figure 4.4 with Figure 4.5, the determined location of 
maximum correlation in Figure 4.4 is an acceptable match, while the determined 
location of maximum correlation in Figure 4.5 is just noise.  Now, whenever an 
erroneous match is discovered, as in the example above, that value is replaced with an 
average of the velocities occurring before and after the event.   
 
 
 
Figure 4.4:  Correlation coefficient values for various window locations from Picg.  Note 
the extent of the maximum as compared with the rest of the surface.  This would be 
constituted as an acceptable match. 
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Figure 4.5:  Correlation coefficient values for various window locations from Picg.  Note 
the extent of the maximum as compared with the rest of the surface.  This would be 
constituted as a poor match. 
 
 
 
 Another problem often encountered was that of motion artifact due to sudden 
movements by the animal or occasional intestinal motility at the imaging site.  Since the 
magnification was so large, even the smallest movements could cause problems.  
Initially the velocity reference window created was not dynamic, but rather stayed in the 
same location for each given sequence during analysis.  This made window matching 
difficult or even irrelevant if the window drifted partially or sometimes completely 
outside of the vessel.  To correct this, the velocity calculations were implemented after 
the diameter measurements were made, so that the reference window could always be 
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placed in the center of the diameter.  This also allowed us to change the width of the 
window to match the vessel’s diameter (0.8*diameter), since as noted before a larger 
window size improves the chances of an acceptable match. 
 
4.1.4 Increasing lymphocyte density 
 Since one of the main limitations of this technique is the necessity of high 
lymphocyte densities, a method was sought to increase this density naturally.  It had 
been noted previously by others that after ingestion of lipids, the lipids are packaged into 
chylomicrons by the enterocytes of the small intestine and taken up into the lymphatics 
[98, 99].  In addition to this, lymphocyte concentration has been shown to increase 
temporarily after lipid absorption [54].  To harness this effect for improving our in situ 
conditions, we fed the rat a small amount of cream and waited approximately 20 minutes 
before beginning the in situ procedure.  Doing this greatly enhanced the number of 
lymphocytes in our field of view (Figure 4.6); however, since the rat was no longer 
fasted, motion artifact through intestinal motility was greatly increased.  The effects of 
this method are also only temporary and are therefore not useful after about an hour of 
imaging. 
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Figure 4.6:  Mesenteric vessel of a rat approximately 45 minutes after being fed cream.  
Notice the increase in lymphocyte density as compared to Figure 4.1. 
 
 
 
4.1.5 Isolated vessel protocol 
 We decided to perform further tests with the image correlation algorithm to see 
how well it would work with isolated vessels and to determine the actual velocities that 
occurred for various inlet and outlet pressures that were being applied.    All animal 
procedures performed for this study were reviewed and approved by our institutional 
animal care and use committee, the Texas A&M University Laboratory Animal Care 
Committee.  To isolate a mesenteric lymphatic, rats were euthanized with pentobarbital 
(120 mg/kg body weight IP).  An abdominal incision was made to gain access to the 
mesenteric lymphatic vessels.   A loop of the small intestine was exteriorized through the 
incision and gently positioned over a semicircular viewing pedestal on a Plexiglas 
preparation board. A lymphatic vessel was then carefully cleared of all surrounding 
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tissues using a dissecting microscope. Extreme caution was used to not grab or pinch the 
vessel at any time, thereby reducing the likelihood of damage. The area of interest was 
kept moist for the period of dissection using the standard Dulbecco’s Phosphate-
Buffered Saline (Invitrogen Corp. 14040-133).  A mesenteric lymphatic vessel 1-2 cm 
long was dissected and used for experiments.  Once the vessel was exteriorized, the 
lymphatic segment was transferred to an isolated vessel chamber (modified Living 
Systems Instrumentation single vessel chamber model CH/1) filled with room 
temperature albumin-physiological salt solution (APSS) (in mM: 145.0 NaCl, 4.7 KCl, 
2.0 CaCl2, 1.17 MgSO4, 1.2 NaH2PO4, 5.0 Dextrose, 2.0 Sodium Pyruvate, 0.02 EDTA, 
3.0 MOPS, and 10g/l bovine serum albumin) pH adjusted to 7.36 at 38o C.  The isolated 
segment was cannulated and tied onto two carefully matched glass pipettes (100-200 
µm).  Great care was used to prepare and select pairs of resistance-matched pipettes for 
these experiments.  For each experiment we chose pairs of pipettes with matching 
diameters and tip lengths and we tested them to ensure that the difference between their 
measured electrical resistances did not exceed 10% [100].  The pipettes were filled with 
a 0.97 µm polystyrene microsphere suspension diluted into an APSS solution at a ratio 
of 1:500.  Microspheres were needed to act as the particles that the correlation algorithm 
would track.  The inflow and outflow pipettes were connected to independently 
adjustable pressure reservoirs filled with APSS.  Care was taken to ensure that there 
were no air bubbles in the tubing or in the pipettes.  Once the vessel was cannulated, a 
slight positive transmural pressure (2-3 cm H2O) was applied to it to detect leaks and to 
ensure that the vessel was undamaged and untwisted.  The vessel was set to its 
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approximate in situ length and positioned just above the glass coverslip comprising the 
chamber bottom.  The vessel chamber was then transferred to the stage of a microscope.  
The vessel was set to an equilibration transmural pressure of 3 cm H2O and warmed to 
38o C during 15-20 minutes.  Once tone and spontaneous contractions were observed, the 
segments of data were recorded with the high speed camera (Dalstar64K1M, 1M fps 
245x245, CCD camera) at various inflow and outflow pressures.  We waited five 
minutes between each recording sequence to allow for the previous data set to be saved 
to the hard drive and to give the vessel time to equilibrate to the new pressures. 
 
4.2 Results and Discussion 
4.2.1 In situ experiments 
 A sequence of data, represented in Table 3.2, was taken from Rat 6 and 
processed through the developed correlation algorithm (Figure 4.7).  As one can see 
from the figure, the program successfully picked out fluctuations in velocity; however, 
there are numerous segments of data that appear to be noise.  The standard error of 
prediction for this case sequence was 0.8479 mm/sec.  While one could easily remove 
the points classified as “noise” after comparing them with the manually tracked data, a 
method was sought to consistently improve the noise level without having to use the 
manual data analysis.  To do this, several improvements to the correlation algorithm 
were made, as mentioned in the materials an methods section (4.1.3). 
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Figure 4.7:  Comparison of spatially averaged velocity calculated from manually tracked 
data with that of the correlation algorithm.  The standard error of prediction was 0.8479 
mm/sec. 
 
 
 
 As described in the materials and methods section (4.1.3), one other modification 
that was made to improve the lymphocyte velocity measurements was to create a method 
for removing “bad” data points by comparing the correlation coefficient at the best fit 
with the correlation coefficients spatially surrounding that fit.  This, in conjunction with 
the dynamic reference window, improved the data dramatically (Figure 4.8).   
 One question that arises from this is whether or not the displacement of the 
reference window found by the program is actually a measure of spatially averaged 
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velocity (V ) (assuming Poiseuille flow V  would be half of the maximum velocity 
( )).  This should be the case if there is an even distribution of lymphocytes across 
the radius of the vessel.  However, if there are more lymphocytes in the center of the 
vessel than near the wall, the displacement of the window would approach the center 
velocity (i.e. ) instead (Figure 4.9).   
maxV
maxV
 
 
Figure 4.8:  Comparison of spatially averaged velocity calculated from manually tracked 
data with that calculated by the correlation algorithm after modifications were made to 
improve the algorithm.  The standard error of prediction is 0.5009 mm/sec. 
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Figure 4.9:  Comparison of maximum velocity calculated from manually tracked data 
with that calculated by the correlation algorithm after modifications were made to 
improve the algorithm.  The standard error of prediction is 0.4850 mm/sec. 
 
 
 
 Of course, in order for to be the best match, all of the tracked lymphocytes 
would have to be in the center, which is unlikely to be the case if you have more than 
one lymphocyte located in a given cross section of the vessel.  It seems logical then, that 
the physical representation of the velocity calculated by the correlation algorithm is 
larger than 
maxV
V  (since particles tend to locate themselves near the center) and lower than 
 (since all of the particles cannot flow through the center).  To see if this is the case 
for this particular set of data, a program was written in Matlab to vary the velocities 
maxV
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calculated from the manually tracked data from V  to maxV , while keeping the correlation 
tracked velocities the same, and find the minimum standard error of prediction for the 
correlation method (Figure 4.10).  For this particular case the best fit occurred at 
VVV 45.055.0 max
* +=  (Figure 4.11). 
 
 
Figure 4.10:  The standard error of prediction as the manually tracked velocity is varied 
from V  to maxV where W on the x-axis is represented by the equation 
VWVWV )1(max
* −+×= . 
 
 
 
87 
 When the program is being run on a data set where there is no manually tracked 
data to which it can be compared, at least as of now there is no way as of now to tell 
whether the velocities being measured are closer to the spatially averaged velocity or the 
maximum particle velocity as this will depend on the radial distribution of the total 
number of particles.  In Chapter V, I have laid out some future work that could be done 
to take the spatial distribution of lymphocytes into account. 
 
 
Figure 4.11:  Comparison of the optimized velocity ( VWVWV )1(max
* −+×= ) 
calculated from manually tracked data with that calculated by the correlation algorithm.  
The standard error of prediction is 0.4333 mm/sec. 
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 After optimizing and finalizing the algorithm on this particular set of data, we 
wanted to test it on other in situ data runs.  A few sequences of data were chosen that 
had a large enough lymphocyte density to ensure that there were multiple lymphocytes 
in the field of view at every time interval during the sequence.  This limited the number 
of manually tracked data sets that could be used and thus compared to the correlation 
method, but each of them represents a different vessel and rat so as to establish the 
robustness of the program provided there are enough lymphocytes available (Figure 4.12 
and Figure 4.13).  I have tried to represent two extreme situations here, with Figure 4.12 
illustrating a vessel with several rapid changes in velocity and Figure 4.13 exemplifying 
a vessel that experienced just a few spontaneous contractions and thus not much velocity 
fluctuation. 
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Figure 4.12:  Another data sequence comparing the velocities calculated by the 
correlation algorithm with V  calculated from the manually tracked data.  The standard 
error of prediction is 0.3894 mm/sec. 
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Figure 4.13:  Another data sequence comparing the velocities calculated by the 
correlation algorithm with V  calculated from the manually tracked data.  The standard 
error of prediction is 0.2005 mm/sec. 
 
 
 
 Given that pV is the predicted velocity determined by the correlation algorithm, 
the equation used for finding the standard error or prediction is: 
(4.4)  ( )∑
=
−=
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e
0
2
)()(1  
One should be able to see from this equation that the best achievable standard error of 
prediction is determined by the resolution of the system.  The smallest discernable shift 
in the correlation window is one pixel.  If this value is divided by the time interval 
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between the image sets used in the correlation algorithm (8 ms), then the velocity 
resolution of the system is 125 pixels/sec. While the corresponding actual resolution 
varies with the magnification used, it is typically around .125 mm/sec; therefore, a 
standard error of prediction of approximately .200 mm/sec is actually getting fairly close 
to the resolution of the current system.  The resolution could be improved by increasing 
the time interval between the image sets used by the correlation program; however, this 
would decrease the maximum detectable velocity of the system.  Eight milliseconds 
seems to be an optimal time interval between image sets.   
 It was also suggested that the program could be improved by altering the shape 
of the second velocity window to fit the assumed Poiseuille flow distribution. This 
alteration could be done by finding an initial guess of the velocity using two square 
windows and then deforming the second window by an amount proportional to that 
guess.  The program could then reiterate this procedure to give you a better guess and 
could continue either a fixed number of times or until you converge on some solution.  
While the code to do this was written and has been included in Appendix IV, the results 
it produced were actually noisier than those produced using the square window.  I think 
the main reason for this noise was due to the “particles” size being around 5-7 pixels so 
that if the window was shifted based upon the radial location of each pixel, then the 
expected shape of the lymphocytes were actually distorted, which does not actually 
happen physically. 
 As stated before mesenteric lymphatic vessels undergo drift in the imaging field 
due to various forms of motion artifact.  This drift can have a huge impact on the 
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original method used above for measuring velocity since the reference window created 
in Pic f was static.  If the window drifted outside of the vessel or even partially out of the 
vessel, the results were seriously altered.  The main way to correct for this was to take 
into consideration the spatial location of each of the vessel walls so as to always postion 
the reference window in the center of the vessel.  In doing this, not only did we improve 
the algorithm, but our algorithm allowed us to track movements in the vessel diameter as 
well (Figure 4.14).  The main discrepancies between the manually tracked diameters and 
those determined according to the algorithm are more than likely due to inconsistencies 
in where the user measured in each image.  Fortunately, the correlation algorithm is 
completely consistent in where it measures vessel diameter each time.  The accuracy of 
the diameters determined from the correlation algorithm can be verified through visual 
inspection by overlaying the computer’s projection of the wall with the image itself 
(Figure 4.15). 
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Figure 4.14:  Diameter tracings calculated by the correlation algorithm compared with 
those calculated from the manually tracked data.  The standard error of prediction is 6.8 
µm. 
 
 
 
   While it cannot be shown visually here, a movie was actually created that shows 
an animated version of Figure 4.15 with the computer tracking the variations in vessel 
diameter.  It should be noted, however, that when there are fat cells overlapping the 
vessel, something that can occur quite often with mesenteric vessels, the user can “work 
around” the fat cells, while the program cannot always distinguish between the edge of a 
fat cell and the edge of the vessel wall.  One should also be aware that it makes a 
difference where the vessel wall is measured. The vessel is not exactly a straight tube, 
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and sometimes the vessel contracts more strongly in some portions than in others (Figure 
4.16).   
 
 
 
Figure 4.15:  Image correlation was used to track the wall at multiple locations and fit 
them together with a line.  This image represents a snapshot of a movie showing the 
program’s ability to continuously and accurately track wall movement. 
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Figure 4.16:  Diameter measurements taken at three different locations of the vessel (top, 
middle, and bottom).  In this case the vessel narrows as you go from top to bottom, and 
the vessel also contracts more strongly at the bottom. 
 
 
 
4.2.2 Increasing lymphocyte density through lipid absorption 
 As mentioned in section 4.2.4, after we had tested the program on the original in 
situ experiments, we decided to run the algorithm on data sets where we had tried to 
increase the lymphocyte concentration by feeding the rats some cream before surgery.  
The best way to illustrate the advantage of having a large lymphocyte density is to 
compare the results of a rat that has been fed cream and thus has more lymphocytes with 
one that has a low density (Figure 4.17 and Figure 4.18).     
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Figure 4.17: A 3 second portion of a velocity fluctuation measured with the image 
correlation method for a “lipid enhanced” rat with a large lymphocyte density. 
 
 
 
Figure 4.17 shows a 3 second interval of data where the correlation program could 
continuously measure the velocity throughout the time interval with very little noise.  
Figure 4.18 was generated by the correlation program using the data set represented at 
approximately time t = 4 sec in Figure 2.11.  While it is not evident from Figure 2.11, 
the lymphocyte density is fairly low for this particular sequence.  The spikes from t = 1.5 
sec to 2.5 sec in Figure 4.18 do not represent fluctuations in fluid flow, but are rather 
periods during the flow in which there are no lymphocytes in the correlation window. 
Therefore, the best match found by the program is at the site of the original window, 
97 
which gives a velocity of 0 mm/sec, when in fact the fluid is moving at a much higher 
speed. 
 
Figure 4.18:  A 3 second portion of a velocity fluctuation (from Figure 2.11 at ~ t = 4 sec) 
measured with the image correlation method, lymphocyte density was very low. 
 
 
 
4.2.3 Using the image correlation method with isolated vessels 
 Preliminary tests on isolated vessels demonstrated the capability of the 
correlation algorithm to measure flows being applied under various input and output 
pressures, provided one can seed the media flowing through the vessel with particles that 
are at least ~ 1 micron in diameter (Table 4.1).  Outflow, P(out), and inflow P(in) 
pressures are reported in cmH2O. 
98 
Table 4.1:  Measurement of contraction and flow parameters as calculated by the 
correlation program for various pressure gradients for two different experiments (1 & 2). 
  P(in) P(out)
Avg Vel 
(mm/sec) 
Max Vel 
(mm/sec)
Avg 
Diam 
(µm) 
Max 
Diam 
(µm) 
Min 
Diam 
(µm) 
RMS 
CV 
(µm/s) 
# 
contract
1 5 5 0.22 10.11 158.5 169.7 94.4 106.3 3.50
 3 3 0.66 14.05 141.1 165.2 77.5 127.5 5.50
 1 1 0.61 12.36 83.2 107.9 53.9 52.2 3.00
 7.5 2.5 7.21 24.16 159.2 171.9 114.6 76.4 4.00
 6.5 3.5 8.46 28.09 134.8 160.7 98.9 77.6 6.25
 5.5 4.5 3.74 19.66 145.5 165.2 112.4 62.8 4.50
 4.5 5.5 0.60 6.74 97.7 140.5 75.3 39.0 4.50
                    
2 5 5 0.30 5.62 133.4 143.8 103.4 59.3 6.00
 3 3 0.36 5.62 133.4 137.1 109.0 39.9 3.00
 1 1 0.05 3.93 121.1 128.1 95.5 31.3 2.00
 7.5 2.5 1.08 5.06 149.3 159.6 119.1 49.7 5.00
 6.5 3.5 0.38 2.81 154.7 161.8 119.1 43.4 2.75
 5.5 4.5 0.20 3.93 158.8 164.0 113.5 29.4 1.00
 4.5 5.5 -0.14 0.56 142.8 157.3 106.7 53.5 4.50
 
 
 The overall responses measured agreed with those found in the literature [25, 45].  
For instance, in Experiment 2 contractile activity increased with increasing transmural 
pressure as measured by the RMS contraction velocity (59.3, 39.9, and 31.3 µm/s).  
Diameter increases with transmural pressure as expected for both Experiment 1 and 2.  
Velocity was also shown to increase, as expected, with increasing pressure gradient 
(0.20, 0.38, 1.08 mm/sec).  However, when one compares the velocity ranges from 
Experiment 1 and 2, it can be seen that they are drastically different even when the 
diameters are similar.  This is most likely due to our inability to ensure that the inflow 
and outflow resistance do not fluctuate from experiment to experiment.  The primary 
source of this fluctuation is due to the microspheres aggregating and clogging the 
outflow pipette tip.  The main difficulty encountered in these experiments was that the 
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microspheres themselves seemed to illicit a physiologic response to the lymphatic 
system.  The microspheres were also affected by the APSS solution in which they were 
placed. Specifically, they began to clump together over time and their surfaces began to 
appear “sticky”.  Initially we tried 5 µm particles due to their similarity in size to 
lymphocytes; however, these particles immediately clogged the pipette tip, which was 
around 50 µm in diameter.  This occurred due to the fairly high density of microspheres 
needed to ensure successful tracking and due to the “sticky” effect that we had observed.  
We tried various sizes of microspheres and the 0.95 micron diameter spheres were the 
only ones that did not clog the pipette tip.  At first we were unsure if this size would 
work with the correlation program since they were smaller than the resolution of our 
image (1 µm ~ 1 pixel).  When they began to aggregate together, the groups were the 
ideal size to allow for tracking and yet still prevent clogging (~3-4 µm).  On several 
occasions we observed the particles sticking to the valve leaflets and thus increasing the 
flow resistance, which probably explains some of the variability that we saw when 
comparing the two data sets with one another.  It is also highly likely that the 
microspheres are damaging the endothelial cells of the vessel, since in many cases the 
vessel stopped contracting under conditions that would normally enhance contraction.  
While the program will work quite well for tracking these microspheres in isolated 
vessels, if this method is to be used in physiologic studies with isolated vessels, there 
needs to be a way to better minimize the effects of the seeded particle on the vessels 
themselves. 
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4.3 Concluding Remarks 
 Through various experiments I have demonstrated the capability of image 
correlation approaches to measure fluctuations in diameter of contracting mesenteric 
lymphatics.  While there are many well established approaches for measuring the 
diameter of vessels [101-103], it was advantageous to measure them through our image 
correlation program.  This ensured that our measurements could be used to optimize our 
ability to track lymph flow within the image correlation program by temporally adjusting 
the correlation window according to the vessel contractions.  The program has proven to 
be quite robust at detecting temporal fluctuations in lymph flow.  For all the cases that it 
was tested, the actual velocity appears to be somewhere between the spatially averaged 
velocity and the maximum velocity, although its exact value presumably depends on the 
radial distribution of the lymphocytes.  If one wanted to obtain measurements to be used 
in more detailed fluids modeling, this program would not provide the sufficient accuracy 
necessary to do so.  We have provided, however, a large database of quantitative 
measurements of flow in Chapter III should one need more accurate measurements for 
further fluid dynamics modeling.  This methodology will work quite well for future 
physiological studies, provided that the main parameter of interest is measuring temporal 
fluctuations in flow before and after various conditions are imposed on the vessel. 
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CHAPTER V 
CONCLUSION AND FUTURE WORK 
 
 The role of lymphatic vessel contraction in the promotion of lymph flow in 
mesenteric lymphatics was investigated in this research.  While vessel contraction had 
been studied quite extensively in the past, measurements quantifying the velocity 
fluctuations that occur throughout the entire contraction cycle had not been made.  This 
lack of data was partly due to the large dynamic range of velocities that we found to 
occur in mesenteric lymphatics using our high-speed microscopy system:  from -2 
mm/sec to 10 mm/sec.  In the past, standard video microscopy had not been capable of 
measuring these speeds due to the large magnifications necessary to observe these 
smaller vessels (~100 µm in diameter).  Knowing these velocity ranges not only 
improved our understanding of each individual lymphangion’s role in promoting lymph 
flow, but it also has provided the background necessary to pursue flow studies in isolated 
vessels and in cell culture models.  For example, it had previously been shown that 
imposed flow produced an inhibition of the lymphatic intrinsic pump; however, it was 
not known for certain whether the velocities applied to the isolated vessels in this study 
represented the actual velocities that would occur in vivo.  Until these velocities could be 
verified, the conclusions of such experiments would always be in question.   
 Of course, ultimately it is not velocity itself that produces this inhibition, but 
rather the sensitivity of the endothelial cells lining the vessel wall to wall shear stress.  
By taking into account other parameters while measuring the lymphocyte velocity, such 
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as vessel diameter, contraction velocity, and the distance between valves, it was verified 
that Poiseuille flow was a reasonable model for estimating shear stress for a majority of 
the contraction cycle.  These estimations of shear stress will be very important for 
investigators to take into consideration in their future studies on shear dependent 
responses in vitro or in isolated vessels.  The process of verifying the Poiseuille model 
has also demonstrated the need for more extensive modeling if accurate quantifications 
of shear stress for every moment in the contraction cycle are needed.  In brief, the model 
breaks down when the vessel wall velocity approaches the same order of magnitude as 
the lymphocyte velocity.  While this scenario only occurs approximately 20% of the 
time in mesenteric lymphatics, more extensive modeling could potentially provide useful 
information for studying shear stress in low flow situations where the vessel contraction 
has been shown to be very active in isolated vessels.   
 One of the main difficulties encountered in quantifying lymph velocity in these 
experiments was the tedious manual lymphocyte tracking procedure used to process the 
thousands of images generated by the high speed microscopy system and to produce 
only a few minutes worth of data.  It was very important to meticulously process the 
images in the initial studies in order to ensure that the velocities were calculated as 
accurately as possible, since they were intended to provide a framework for future 
studies with isolated vessels and with cell culture models.  This method of processing is 
not , however, ideal for most physiological studies, since it takes so long to acquire the 
final data from each experiment.  Multiple image processing software packages were 
tested with the image sets; however, they all produced spurious results due to the 
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inherent low contrast at the imaging site.  While introduction of fluorescent particles into 
the animal could have enhanced this contrast, it was undesirable to use foreign particles 
with a system that is so closely tied to the immune system.  A method was therefore 
sought that would be able to automatically extract information about lymph flow from a 
sequence of images using the contrast inherent to those image.  This goal was obtained 
through the development of an image correlation program.  By using this program to 
measure vessel wall location first, the algorithm was also able to compensate for motion 
artifact and to process sections of images where particle velocities were known to occur 
(i.e. inside of the vessel walls).  It was demonstrated that the velocities the program 
calculates fall somewhere between the spatially averaged velocity of a Poiseuille flow 
model and the peak center velocity.   As to which value is best represented, it most likely 
depends on the radial distribution of lymphocytes in the vessel.  If the majority of the 
lymphocytes are flowing through the center of the vessel, then the program-generated 
velocity more closely approaches the peak velocity; however, if the lymphocyte density 
is very large, necessitating that the lymphocytes be more evenly distributed across the 
radius, then the program-generated velocity approaches the spatially averaged velocity.  
Future work could be done to quantify this dependence and to develop a method for 
automatically determining lymphocyte distribution, so that a calibration algorithm could 
be written into the program to compensate for it.   
 In its current state, however, this image correlation program should work quite 
well for future physiological studies, provided that the main parameter of interest is the 
temporal fluctuation in flow before and after various conditions are imposed on the 
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lymphatic vessel.  This algorithm could also be modified and implemented to provide 
real time measurements of flow fluctuations, which could be useful for numerous 
physiological studies.  In conclusion, this research has provided quantitative 
measurements of lymphocyte velocity and of various other parameters, has resulted in 
estimations of wall shear stress that have proven to be reasonable for a majority of the 
contraction cycle, has produced a correlation algorithm capable of measuring velocity 
fluctuations with an accuracy of approximately 0.4 mm/sec, and has generated a solid 
framework upon which future studies in lymphatics can build. 
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APPENDIX I 
PROTOCOL FOR PREPARATION OF APSS
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PREPARATION OF APSS (ALBUMIN-PHYSIOLOGICAL SALT SOLUTION) 
 
 
Salt Chemical MW Molarity 
(mM) 
Amount per 1 
liter 
Amount per 2 
liters 
NaCl 58.44 145.000 8.47 g/l 16.94 g/2 l 
KCl 74.56 4.700 0.35 g/l 0.7 g/2 l 
CaCl2 
(CaCl2*2H2O) 
110.99 
(147.02) 
2.000 0.22 g/l 
(0.29 g/l) 
0.44 g/2 l  
(0.58 g/2 l) 
MgSO4 
(MgSO4*7H2O) 
120.37 
(246.48) 
1.170 0.14 g/l  
(0.29 g/l) 
0.28 g/2 l  
(0.58 g/ 2 l) 
NaH2PO4 
(NaH2PO4*H2O) 
119.98 
(137.99) 
1.200 0.14 g/l  
(0.16 g/l) 
0.28 g/2 l  
(0.32 g/ 2 l) 
Dextrose 180.16 5.000 0.9 g/l 1.8 g/ 2 l 
Sodium 
Pyruvate 
100 mM 
solution  
2.000 20 ml/l 40 ml/ 2 l 
EDTA 
(EDTA*2H2O) 
292.25  
(372.2) 
0.020 0.0058 g/l 
(0.0074 g/l) 
0.0116 g/ 2 l 
(0.0148 g/ 2 l) 
MOPS 209.2 3.000 0.628 g/l 1.256 g/ 2 l 
 
 
1. Fill 1 liter volumetric flask with 0.8 liters of RO H2O or 2 liters flask with 1.6 
liters of RO H2O. 
2. Add all above ingredients (for 1 liter or for 2 liters) while mixing and wait them 
to be dissolved. 
3. Add 10 g/liter or 20 g/2 liters of Bovine Serum Albumin (96% minimum) to 
solution and mix until all BSA goes into solution. 
4. Adjust volume to 1 or to 2 liters by RO H2O. 
5. pH all to 7.4 at room temperature. 
6. Filter all (for more that one day storage or for use for vessels perfusion with 
vessels bigger that 0.5 mm in diameter). 
7. Keep refrigerated and tightly closed. 
8. Check pH and adjust if needed to 7.4 at the 38° C before use. 
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APPENDIX II 
DIAMETER AND VELOCITY TRACINGS FOR EACH RAT 
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APPENDIX III 
DOCUMENTED MATLAB CODE 
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%Imagecorrelationwall 
%This program calculates and saves the coordinates of the left and 
right 
%wall at a selected location. 
%It must be run before the Imagecorrelation can be run 
 
%To process an entire sequence of data, you must run the code in the 
following %order: imagecorrelationwall, imagecorrelation, filterdata 
 
clear; 
 
rotangle=-40;  %amount to rotate image to ensure vessel is vertical, 
user     %user will have to determine this by evaluating 
image  
cd 'D:\Rat9\Run2'; %sets the directory to the location of your images 
 
i=2; 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic2=double(imread(t)'); %initializes the image that will be assigned 
to Pic1 
Pic2=imrotate(Pic2,rotangle); 
figure; imagesc(Pic2); colormap 'gray'; 
pixval(1,'on'); 
[y1(1),x1,P] = impixel; %prompts user to select left wall with mouse 
[y2(1),x2,P] = impixel; %prompts user to select right wall with mouse  
pixval('off'); 
X=1; 
while i<6500 
    Pic1=Pic2; %sets Pic1 to the Pic2 image that was used in the 
previous iteration 
    i=i+17 
    X=X+1; 
    if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
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        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
    f = num2str(i); 
    t = strcat(a,f,c); 
    Pic2=double(imread(t)'); 
    Pic2=imrotate(Pic2,rotangle); 
    fwin=Pic1(x1-4:x1+4,y1(X-1)-7:y1(X-1)+7); 
    fbar=mean(mean(fwin)); 
    a=1; 
    for l=(y1(X-1)-7):1:(y1(X-1)+7) 
        gwin=Pic2(x1-4:x1+4,l-7:l+7); 
        gbar=mean(mean(gwin)); 
        num1=(fwin-fbar).*(gwin-gbar); 
        num1=sum(sum(num1)); 
        num2=(fwin-fbar).^2; 
        num2=sum(sum(num2)); 
        num3=(gwin-gbar).^2; 
        num3=sum(sum(num3)); 
        ccorr(a)=num1/sqrt(num2*num3); 
        a=a+1; 
    end 
 
[Y,I]=max(ccorr); 
corvall(X)=Y; 
if Y>0.8 %rejects poor matches and keeps the window location the same 
if      %condition fails 
    y1(X)=y1(X-1)-8+I; %assigns left window location to place of max 
correlation 
else y1(X)=y1(X-1); 
end 
 
 
fwin=Pic1(x1-4:x1+4,y2(X-1)-7:y2(X-1)+7); 
fbar=mean(mean(fwin)); 
 
    a=1; 
    for l=(y2(X-1)-7):1:(y2(X-1)+7) 
        gwin=Pic2(x1-4:x1+4,l-7:l+7); 
        gbar=mean(mean(gwin)); 
        num1=(fwin-fbar).*(gwin-gbar); 
        num1=sum(sum(num1)); 
        num2=(fwin-fbar).^2; 
        num2=sum(sum(num2)); 
        num3=(gwin-gbar).^2; 
        num3=sum(sum(num3)); 
        ccorr(a)=num1/sqrt(num2*num3); 
        a=a+1; 
    end 
[Y,I]=max(ccorr); 
corvalr(X)=Y; 
148 
if Y>0.8 %rejects poor matches and keeps the window location the same 
if      %condition fails 
 
    y2(X)=y2(X-1)-8+I;  %assigns right window location to place of max  
     %correlation 
else y2(X)=y2(X-1); 
end 
end 
diam=(y2-y1);  %this variable must be saved by the user after 
running as     %diameter.mat 
cent=(y2+y1)/2;  %this variable must be saved by the user as 
center.mat 
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%Imagecorrelation 
clear;  
load run2diameter;  
load run2center;  %imports diameter in pixels and pixel location of the 
center    %of the vessel 
 
cd 'D:\Rat9\Run2'; %sets the directory to the location of your images 
 
rotangle=-40;  %amount to rotate image to ensure vessel is vertical, 
user     %user will have to determine this by evaluating 
image 
xi=110;  %makes vertical location of the reference window in the 
center 
for X=1:365 %iterates through each of the 365 sets of 17 images 
for Q=1:4   %chooses 4 image pairings within a set of 17 
i=(X-1)*17+Q %determines image # to load 
if i < 10 %determines format of file string 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic1=double(imread(t)); %reads first image 
 
i=i+2; %iterates to an image 2 frames later for subtraction 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic1b=double(imread(t)); 
 
i=i+2; %iterates to an image 2 frames later for 2nd image set 
if i < 10 
        a = 'lymph000'; 
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        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic2=double(imread(t)); 
i=i+2; % iterates 2 images later for subtraction of image forming 2nd 
set 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic2b=double(imread(t)); 
 
Pic1=(Pic1-Pic1b)';  %assumes the image read is in the horizontal 
position, 
    % ' switches it to vertical, forms subtracted 
image pair 
Pic2=(Pic2-Pic2b)'; % forms 2nd subtracted image pair 
Pic1=medfilt2(Pic1, [5 5]); %applies low pass filter to remove 
pixilation noise 
Pic2=medfilt2(Pic2, [5 5]); 
Pic1=imrotate(Pic1,rotangle); %rotates image by amount specified 
earlier 
Pic2=imrotate(Pic2,rotangle); 
 
fwin=Pic1(xi-15:xi+15,(cent(X)-diam(X)/2+5):(cent(X)+diam(X)/2-5));  
%horizontal window size is set as a function of the diameter 
% and the center of the vessel 
 
fbar=mean(mean(fwin));                                               
a=0; 
for k=xi-50:xi+50 %scans the window vertically to measure fluid 
displacement 
    a=a+1; 
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    b=0; 
    for l=cent(X)-6:cent(X)+6 %scans the window horizontally to 
compensate for      %image shifting due to motion 
artifact 
        b=b+1; 
        gwin=Pic2(k-15:k+15,(l-diam(X)/2+5):(l+diam(X)/2-5));  
%gwin window size must be identical to fwin 
        gbar=mean(mean(gwin)); 
        num1=(fwin-fbar).*(gwin-gbar); 
        num1=sum(sum(num1))/400; 
        num2=(fwin-fbar).^2; 
        num2=sum(sum(num2))/400; 
        num3=(gwin-gbar).^2; 
        num3=sum(sum(num3))/400; 
        Data(X,Q).ccorr(a,b)=num1/sqrt(num2*num3);  
%saves all the correlation images in file Data(X,Q)to be processed by 
%processcorr and filterdata  
 
end %for l                                                
     
end %for k 
 
end %for Q 
end %for X 
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% Processcor 
% the image correlation program must be run first and the variable Data 
must be % in the workspace 
% this program need not be executed as it is a subprogram used by 
filterdata 
% the main difference between this program and Processcor2 is that 
Processcor2  
% averages all 4 runs in a 17 image set, while this one chooses the 
best of  
% the four 
 
clear temp1 temp2 maxval corval num i j bestps bestcv bestps2 
 
for x=1:365 
    for y=1:4 
        [temp1, temp2]=max(Data(x,y).ccorr'); 
        [maxval(x,y),maxloc(x,y)]=max(temp1);  
   %chooses the best match of each of the 4 pairings in a set of 
17 images 
        corval(x,y)=maxval(x,y)./mean(mean(abs(Data(x,y).ccorr)));  
   %calculates relative correlation coeff 
    end 
    [num,i(x)]=max(corval(x,:));  %chooses the best of the 4   
    [num,j(x)]=max(maxval(x,:));     
    bestps(x)=maxloc(x,i(x)); %based on relative CC 
    bestcv(x)=corval(x,i(x)); 
    bestps2(x)=maxloc(x,j(x)); %based on absolute CC 
end 
% figure; 
% plot(bestps); 
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% Processcor2 
% the image correlation program must be run first and the variable Data 
must be % in the workspace 
% this program need not be executed as it is a subprogram used by 
filterdata 
% the main difference between this program and Processcor is that this 
one  
% averages all 4 runs in a 17 image set, while Processcor chooses the 
best of  
% the four 
 
clear temp1 temp2 maxval corval bestps bestcv tempdata 
 
for x=1:365 
    tempdata(x).ccorr=Data(x,1).ccorr; 
    for y=1:4 
        tempdata(x).ccorr=tempdata(x).ccorr+Data(x,y).ccorr;        
   %sums each of the 4 pairings into a single correlation matrix 
for each    %of the 17 image sets  
    end 
    tempdata(x).ccorr=tempdata(x).ccorr/4; %computes the average 
[temp1,temp2]=max(tempdata(x).ccorr');  
 %finds the column in which the maximum correlation value is 
contained    
[maxval(x),bestps(x)]=max(temp1);     
%finds the row in which the maximum correlation window is contained 
corval(x)=maxval(x)/mean(mean(abs(tempdata(x).ccorr)));  
%calculates the relative correlation coefficient 
end 
% figure; 
% plot(bestps); 
bestcv=corval; 
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% Filter data – the last program to be run in the sequence 
 
 
Processcor2; %calls the subprogram can be Processcor2 or 1 see 
documentation for 
   %difference 
 
velocity=(bestps-51)*0.001005814/.008;   
%0.00100518 is dimension per pixel in mm, depends on optical settings 
 
err=sqrt(mean((manualv'-velocity).^2)) 
 
cutoff=5.0; %sets the value the corr coeff must be to be a good match 
found=0; 
y=1; 
while found==0 %searches for the first good fit 
    if bestcv(y)<cutoff 
        y=y+1; 
    else 
        found=1; 
    end 
end 
found=0; 
z=365; 
while found==0  %searches for the last good fit 
    if bestcv(z)<cutoff 
        z=z-1; 
    else 
        found=1; 
    end 
end 
for x=y:z  %looks at all values between first and last good fits 
        if bestcv(x)<cutoff   
 
%is it’s a poor match this sequence of if then statements search the 
data to  
%find the closest good matches before and after and user linear 
interpolation to  
%replace the bad match 
             
  findlower=0; 
            findupper=0; 
            a=1; 
            while findlower==0 
            if and(bestcv(x-a)<cutoff,(x-a)>0) 
                a=a+1; 
            else 
                findlower=1; 
                lownum=x-a; 
            end %if 
            end %while findlower 
            a=1; 
            while findupper==0 
            if and(bestcv(x+a)<cutoff,(x+a)<350) 
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                a=a+1; 
            else 
                findupper=1; 
                highnum=x+a; 
            end %if 
            end %while fundupper 
            bestps(x)=bestps(lownum)+(bestps(highnum)-
bestps(lownum))/(highnum-lownum)*(x-lownum); 
        else 
            bestps(x)=bestps(x); %accepts good matches 
        end %if best 
    end  
    %figure;  
    %plot(smooth(bestps)); 
    %hold; 
%     plot(bestps, 'r'); 
mean(bestps) 
mean(bestcv) 
velocity=(bestps-51)*0.001005814/.008; 
%0.00100518 is dimension per pixel in mm, depends on optical settings 
 
err=sqrt(mean((manualv'-velocity).^2))  
%calculates the standard error of prediction assuming you already have 
a vector  
%of manually recorded values in the workspace saved as manualv 
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%Findbestfit 
%this program weighs the manually tracked data from spatially averaged 
velocity  
%to max velocity and calculates the error of this weighing as compared 
with the  
%correlation program 
 
for x=0:100 
     
weight=.01*x; 
fitvel=manualv*weight+sav*(1-weight); 
% figure; plot(fitvel, '*'); 
% hold; 
% plot(velocity); 
 
err(x+1)=sqrt(mean((fitvel'-velocity).^2)); 
end; 
157 
%Makemovie 
%this program makes a movie from a sequence of lymphatic images 
 
x=0; 
figure; 
colormap 'gray'; 
for i=0*17:17:365*17 
    x=x+1; 
    if i < 10 
        a = 'rat000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'rat00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'rat0'; 
        c = '.tif'; 
    else 
        a = 'rat'; 
        c = '.tif'; 
    end 
    f = num2str(i); 
    t = strcat(a,f,c); 
    Pic(x).picture=double(imread(t)'); 
    imagesc(Pic(x).picture); 
    F(x)=getframe; 
end 
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%Imagecorrelationwinchage 
%clear; 
%This program changes the second window to fit that of a parabolic flow 
profile. 
%It was tested on Rat9Run3 
%Last modified 8/11/05 
 
for X=3:3 %Number of velocities you want to calculate 
    cd 'c:\corrtest'; 
Vnew=0; %initialize 
V(X)=0; %initialize 
i=(X-1)*17+1 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic1=double(imread(t)); 
i=i+2; %Loads an image to images later to subtract from the original 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic1b=double(imread(t)); 
i=i+2; 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
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        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic2=double(imread(t)); 
i=i+2; %Loads an image to images later to subtract from the original 
if i < 10 
        a = 'lymph000'; 
        c = '.tif'; 
    elseif i <100 
        a = 'lymph00'; 
        c = '.tif'; 
    elseif i <1000 
        a = 'lymph0'; 
        c = '.tif'; 
    else 
        a = 'lymph'; 
        c = '.tif'; 
    end 
f = num2str(i); 
t = strcat(a,f,c); 
Pic2b=double(imread(t)); 
Pic1=Pic1-Pic1b; 
Pic2=Pic2-Pic2b; %Pic2 is seperated by 2*framerate from Pic1 
Pic1=medfilt2(Pic1, [5 5]); %smooths out pixel noise 
Pic2=medfilt2(Pic2, [5 5]); 
fwin=Pic1(x1-15:x1+15,y1(X)+15:y2(X)-15);  
%sets the window on Pic1, y1&y2 are the left and right wall edges which 
are %found by running Imagecorrelationwall 
fbar=mean(mean(fwin)); 
count=0; %initialize 
while and(or(abs(Vnew-V(X))>0,count<1),count<6)  
%condition ensures that loop is run from 1 to 6 times and quits if it 
produces a %reduntant value 
V(X)=Vnew; %assigns previously found value to V(X) 
count=count+1; 
Pic2disp=Pic2; %Pic2disp will be the Pic2 image shifted to compensate 
for the  
     %velocity distribution 
p2davg=mean(mean(Pic2disp)); 
for k=y1(X)+15:y2(X)-15 
    disp=round(-1.5*V(X)*(1-((k-(y1(X)+y2(X))/2)/((y1(X)+y2(X))/2-
y1(X)))^2)); %calculates the disp based on measured V(X), was not sure 
if V(X) was centerline %or average velocity, so used the mean of the 
two instead 
    for l=1:252 
        if and((disp+l)<=252,(disp+l)>=1)  
   %can't displace beyond the image border 
            Pic2disp(l,k)=Pic2disp(l+disp,k); 
        else 
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            Pic2disp(l,k)=p2davg; %assigns a background value to 
references beyond the image edge 
        end %if 
    end %for l 
end %for k 
for k=51:200  
%this nested loop moves the second window around and calculates the  
%correlation 
        a=k-50; 
        for l=-4:4 
        b=l+5; 
        gwin=Pic2disp(k-15:k+15,y1(X)+15+l:y2(X)-15+l); 
        gbar=mean(mean(gwin)); 
        num1=(fwin-fbar).*(gwin-gbar); 
        num1=sum(sum(num1))/400; 
        num2=(fwin-fbar).^2; 
        num2=sum(sum(num2))/400; 
        num3=(gwin-gbar).^2; 
        num3=sum(sum(num3))/400; 
        ccorr(a,b)=num1/sqrt(num2*num3); 
        end %for l 
    end %for k 
[corvec,I]=max(ccorr'); %finds all of the maximums in the radial 
direction 
[Y,J]=max(corvec); %finds the maximum in the flow direction 
Vnew=Vnew+(x1-J-50)  
%x1 is the center of window f, J+50 is the center of window g 
end %while loop 
pixshift(X)=Vnew; 
corval(X)=Y; 
relcorval(X)=Y/mean(corvec);  
%finds the max correlation in the flow direction relative to the other 
max  
%correlations in the radial direction 
end %for X=1:350 
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ANIMAL USE PROTOCOL: NUMBER 2004-238 
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Funding Source:               Protocol Number: _________(Assigned by ULACC) 
 Routing Agency:                 Revised 8/04 
 
TEXAS A&M UNIVERSITY 
Research/Teaching Proposals Involving Animal Subjects 
 
Research investigators and class instructors are entrusted with an essential role in assuring 
the humane care and use of animals. In activities you conduct or that are conducted under 
your supervision, you have a direct and continuing responsibility to ensure that animals are 
adequately cared for and used in a humane fashion. Investigators and instructors must ensure 
that discomfort, pain or injury to the animals is avoided or minimized, consistent with sound 
experimental/teaching design; that no more animals are used than are necessary to reach 
sound scientific conclusions or to teach the class; and that, when appropriate, animals are 
painlessly sacrificed in accordance with methods of euthanasia approved by the Panel on 
Euthanasia of the American Veterinary Medical Association.  Forms and requirements for 
approval by the Institutional Biosafety Committee (IBC) can be accessed through the 
ULACC web page (http://animal.tamu.edu). 
 
Please check below if your research/teaching protocol involves any of the following: 
      Decapitation or cervical dislocation without anesthesia [Provide rationale in Section 
II.E] 
      Death (without appropriate euthanasia) as an experimental endpoint [Complete 
Section III.D.4] 
      More than momentary pain and distress not relieved by anesthesia and/or analgesics 
  x    Surgery [Complete Attachment 1: Surgical Procedures] 
__ Multiple major survival surgery [Provide rationale in Attachment 1] 
      Use of adjuvants or antibody production [Complete Attachment 2: Antibody 
Production] 
      Use of hazardous chemicals (including chemical carcinogens) or radioactive 
materials [Complete Attachment 3 for each]      
      Use of recombinant DNA or genetically altered materials [Provide IBC Approval]   
        Use of agents infectious for personnel [Provide IBC Approval] 
___   Use of a select agent or biological toxin [See Appendix 2 of IBC permit form for list] 
      Use of non-commercial genetically modified animals [Provide IBC Approval] 
      Captured wild animals or field studies [Complete Attachment 4: Field Studies] 
 
Complete the Information Below: 
Investigator/Instructor Name: David C. Zawieja Department: Medical Physiology  
Mail Stop:     1114 
 
Project/Class Title: Influences of lymph flow on the lymphatic pump 
 
Is this AUP intended for continued work on a funded grant?  (i.e.  AUP was approved before 
grant?) 
____No  
__X__Yes (Previous AUP # 2001-252 ) 
 
Is this AUP intended to replace another approved AUP?  
_X__No 
       Yes (Replaced AUP #________________) 
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FOR COMMITTEE ACTION ONLY 
Animal usage (pertains to project design, not to species): 
 ______Experiments involving food or fiber research or production (IAACUC) 
 ______Experiments of a biomedical nature (ULACC) 
 ______Client-Owned Animals (CVM CRRC) 
 ______Experiment Station (PHS or USDA Regulated Species, ULACC) 
 
Pain Stress Category Assigned: I II III IV 
USDA Category Assigned: N/A C D E 
 
______ Returned for modification 
______ Approved by ULACC/IAACUC Date: ________   Signature: 
___________________________________ 
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INVESTIGATOR’S/INSTRUCTOR’S ASSURANCE 
 
Texas A&M University (TAMU) recognizes the importance of the use of animals in its research, 
teaching, and testing programs, and is committed to maintaining high standards for the care and use of 
animals in research, teaching, and testing. TAMU has adopted the “U.S. Government’s Principles for 
the Utilization and Care of Vertebrate Animals Used in Testing, Research and Training” and complies 
with all applicable portions of the Animal Welfare Act, the Public Health Service Policy for the 
Humane Care and Use of Laboratory Animals, and all other federal, state, and local laws which impact 
the care and use of animals.  TAMU investigators, teachers, staff, and students accept responsibility for 
determining that research, teaching, and testing involving the use of animals fulfills these principles, 
policies, and regulations. To assure compliance: 
 
•APPROVAL OF AUPS Approval of an Animal Use Protocol (AUP), by the appropriate Institutional Animal Care 
and Use Committee (University Laboratory Animal Care Committee, ULACC, or Institutional Agricultural Animal 
Care and Use Committee, IAACUC), is required for all vertebrate animal use.  All vertebrate animals must be 
covered by an active AUP, even after termination of a project. 
 
•DURATION OF APPROVAL AUPs are approved for a three-year period and require two annual reviews.  The 
first annual and second annual reviews are due on the anniversary of the date the ULACC/IAACUC approved the 
protocol.  A new AUP approval is required for continuation beyond the three-year period. 
 
•AMENDMENTS TO AUPS Any proposed change in personnel, species usage, animal procedures, anesthesia, 
post-operative care, or biohazard procedures to the animal portion of a study must be reported in writing to the 
ULACC/IAACUC for approval.  Committee approval of the proposed amendment is required prior to proceeding 
with the revised animal procedures. 
 
•INFECTIOUS BIOHAZARDS, RECOMBINANT DNA All animal research projects involving infectious 
biohazards and   recombinant DNA, including procedures such as introduction of recombinant organisms into 
animals and generation of transgenic or knockout animals, must be registered and approved by the TAMU 
Institutional Biosafety Committee (IBC). 
 
•TRAINING OF PERSONNEL All personnel working with animals, from the animal care staff to the persons 
doing the experiments/teaching must be qualified by training and/or experience to do so.  Such training and/or 
experience should be documented in the AUP.  All personnel working with animals must be informed of the TAMU 
Occupational Health and Safety Program for Animal Care and Use Facilities, and have the opportunity to participate 
fully in the program. 
 
•PROGRAM EVALUATIONS All approved animal housing locations will be inspected twice annually. 
Unannounced inspections and observations of animal quarters and/or experimental or teaching procedures may be 
performed by the attending veterinary staff. Where procedures are causing severe distress to an animal and the pain 
cannot be relieved, veterinarians are authorized to humanely destroy that animal. Institutional Veterinarians will 
make a concerted effort to discuss these situations with investigators/instructors prior to initiating such action. The 
Committee is authorized to suspend research/teaching which does not conform to approved procedures outlined in 
the AUP. 
 
Signature certifies that the Principal Investigator/Instructor: 
1. Understands the requirements of the Public Health Service Policy for the Humane Care 
and Use of Laboratory Animals, applicable portions of the Animal Welfare Regulations 
(Animal Welfare Act), and the Institution's policies governing the use of vertebrate animals for 
research, testing, teaching, or demonstration purposes.   
2.  Will conduct the project/course in full compliance with the aforementioned 
requirements. 
3.  Will assure that personnel are appropriately trained and will conduct all procedures as 
described in this AUP. 
4.  Assures that this AUP accurately reflects the research/teaching described in any 
accompanying grant proposal. 
5.  Assures that the proposed work does not unnecessarily duplicate previous experiments. 
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6.  Understands that work with animals is limited specifically to what is approved in this 
document. 
 
David C. Zawieja Ph.D           __________________________________                  
________ 
Typed Name of Investigator/Instructor           Signature of Principal Investigator/Instructor                     
Date 
 
(NOTE: Graduate students need countersignature of Advisor) 
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David C. Zawieja                         Influences of lymph flow on the lymphatic pump            
2001-252 _ 
Principal Investigator/Instructor                             Title of Project/Class                                         
AUP# 
 
 
Certification of ALL Participants in Research/Teaching Procedures 
(Anyone whose name appears in the AUP) 
 
Signature certifies that the participant: 
             1.  Understands the requirements of the Public Health Service Policy for the Humane 
Care and Use of Laboratory Animals, applicable portions of the Animal Welfare Regulations 
(Animal Welfare Act),  and the Institution’s policies governing the use of vertebrate animals 
for research, testing, teaching and for demonstration purposes. 
2.  Will conduct the project/class in full compliance with the aforementioned requirements. 
3.  Understands his/her role in the AUP, agrees to perform it and assures that he/she has the  
      appropriate skills to do so. 
4.   Further understands that work with animals is limited specifically to what is approved in 
this document. 
 
 
Typed Name of Participant             Signature     Date 
 
 
David C. Zawieja Ph.D. 
___________________________________________________ 
 
Anatoliy Gashev 
M.D./Ph.D._______________________________________________ 
 
Steven T. Greiner D.V.M.      
______________________________________________ 
 
______________________________________________________________________ 
 
 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
Please add as many lines as necessary. 
167 
ANIMAL USE PROTOCOL (AUP) 
(For Institutional Review Only) 
 
Instructions to Investigators:  All questions must be answered even if not applicable (N/A). 
This form must be type written.  PLEASE USE AS MUCH SPACE AS NECESSARY TO 
COMPLETELY ANSWER EACH QUESTION.   
 
SECTION I. PROJECT/CLASS IDENTIFICATION 
 
A.   Investigator/Instructor Name: David C. Zawieja 
Dept:Medical Physiology, Mail Stop:1114    
 
Work Phone: 979/845-7465    Emergency Phone: 979/846-3713 
 
 E-mail: dcz@tamu.edu 
    
B. Title of Project/Class: Influences of lymph flow on the lymphatic pump 
   
 Funding Source: NIH 
      (e.g., NIH, USDA, AHA, Teaching, Internal) 
 
 Campus Routing Office: RF 
 (e.g., RF, TAES, TEES, none) 
 
C. Project Animal-Care Contact Person [Who is to be contacted in case of an animal 
emergency]: 
 David C. Zawieja, Anatoliy Gashev, Steven Greiner 
 Work Phone: 845-7465, 862-8575   Emergency Phone: 846-3713, 731-
1147, 731-8838 
 
 E-mail: dcz@tamu.edu, gashev@tamu.edu, stgreiner@msn.com  
 
D. Abstract:  Please provide a brief statement, in LAY TERMINOLOGY, understandable 
by someone with a high school education, with no acronyms or scientific jargon, outlining the 
purpose of the experimental/teaching procedures of this protocol. [Why you are doing this 
experiment/class and what you propose to learn/teach.]        
 The lymphatic system is a network of vessels and nodal tissues dispersed throughout 
the body that has important roles in body fluid and protein circulation, fat absorption and 
immune function. These experiments are designed to determine how fluid flow inside the 
lymphatic vessels affects the pumping activity of the lymphatic vessels. This pumping activity is 
necessary for the generation of lymph flow and for normal lymphatic function.  
 
E. Animal Procedures:  These protocols are available to, and may be read by, the lay 
public.  Describe in narrative form, using LAY TERMINOLOGY, understandable by someone 
with a high school education, no acronyms or scientific jargon, the experimental procedures 
and manipulation or teaching protocol that will be performed on the animals (not scientific 
rationale). [Be brief and specific in describing the animal procedures. However, it is not 
necessary to go into detail (in this section) regarding surgical procedures—that information 
should be addressed on the Surgical Procedures Attachment 1.]        
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The experiments will involve the study of lymphatic vessels removed from the rat. This will 
require tissue harvest from the small intestinal mesentery of the rat after the animal has been 
first fasted overnight and then anesthetized. After the lymphatics are removed from the animal, 
the animal will be sacrificed. 
 
F. Justify why you chose to use this (these) species in your research/class. 
[Describe characteristics of the animal model that make it appropriate for use in your 
studies/teaching*.  Body size, comparative data from prior studies or unique 
physiological features may be considered in justification of species. Cost alone is not 
an acceptable justification for selection of the animal model.]       
 The rat is the animal model of choice because of a number of reasons. The first 
important consideration is size. The animal is small enough to allow us to study the lymphatics 
intact (in situ) on our intravital microscopes, while the vessels are large enough to allow us to 
microscopically observe them but still allow us to manipulate and isolate them. Another 
important factor is that this model has one of the largest literature base published on 
lymphatics and is one in which we have extensive (20years) of experience with both in situ and 
in vitro. 
 
* If this is a teaching protocol please justify the use of live animals to achieve your 
teaching objectives. 
G. Experimental Design/Teaching Protocol 
 
1. Describe the number of animals per experiment/class, including a breakdown within 
experiments/lessons of animals per treatment condition [Including number of replications and 
relevant controls.] If the project involves breeding animals, indicate how many breeder stock 
will be required and how many offspring will be used for the studies.  If the project utilizes a 
colony or herd which will be maintained for the purpose of supplying animals to other 
approved protocols, please contact the Chair of the ULACC/IAACUC for information on 
procedures for documenting colony numbers. 
A CHART OR TABLE PROVIDING EXPERIMENTAL TREATMENT/TEACHING 
LABORATORY AND NUMBER OF ANIMALS PER TREATMENT/TEACHING 
LABORATORY WILL HELP EXPEDITE REVIEW.     
 
See accompanying addendum for table and explanation 
 
2. Explain WHY you chose a certain number of animals per treatment/teaching laboratory 
condition. [Taking into account known variation of the dependent variable, subject losses, etc. 
Statements such as “this number is required for statistical significance”, without an indication 
of how you know this, are not adequate answers. Numbers of animals required to obtain 
enough tissue to adequately quantify parameters may be important, but PI must supply 
indicators of expected tissue content and assay parameters.]   The following URL is used for 
Statistical Calculations:  Number of Animals Needed:  
http://www.stat.uiowa.edu/~Rlenth/Power/index.html. 
Based upon our previous experience and power analyses with similar microlymphatic 
studies, approximately 10 successful experiments will be needed per group, given 
typical variability and measurement sensitivity for these experimental groups. Usually 
we have about about a 75% success rate with these types of experiments meaning we'll 
need ~15 animals per group. However because of the technical difficulty of Project 8, 
we have proposed a greater number of attempted experiments (~20 animals per group) 
because of anticipated, potential lower initial success rates. However we also anticipate 
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that our success rate will improve after the initial studies with new experimental 
paradigms. 
 
SECTION II. ANIMAL PROCUREMENT/MAINTENANCE INFORMATION 
 
A. List the total number of animals used, by species, for the duration of the project: 
 
SPECIES  TOTAL NUMBER FOR 
DURATION OF AUP 
Rat  430 
  
  
 
If the project involves breeding animals, please also complete the table below.  These 
numbers, for the duration of the project, should be included in the overall Total above.  
 
 
SPECIES TOTAL NUMBER OF 
ADULT BREEDERS 
NEEDED 
ESTIMATED TOTAL 
NUMBER OF OFFSPRING 
TO BE PRODUCED 
   
   
 
 
B.Where will you obtain the animals? [If wild-caught by you, please describe applicable 
permits, method of capture and evaluation of health risks to personnel.  Please provide a copy 
of permit approvals (Please contact the chairperson of ULACC if this presents a problem). 
Complete Field Studies Form, Attachment 4, for wild capture studies.]        
 
Commercial Vendors, normally Harlan 
 
 
C.HOUSING (It is the investigators responsibility to assure availability of housing with the 
facility.) 
 
1.  Where will you house animals? __ Reynolds Medical Building _ Bldg. #______________ 
2.  Is it ULACC/IAACUC approved? 
 
    _X_Yes 
 
   _____ No (Please contact the ULACC office at 845-1828 to schedule a facility evaluation.)  
 
3.  Describe any special housing, caging, diet, environment or other requirements necessary for 
this study/class (example:  grid floors, special diets, food/water deprivation, identification of 
genetically modified animals). 
None other than fasting the animals the night before their use. 
 
D.  Who will provide veterinary medical care for the animals? LARR staff Veterinarians 
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E.What will happen to the animals after you complete the experiment/class?  [If you plan to 
transfer the animals at the end of your study, please complete an Animal Transfer Form prior 
to such a transfer. This form is available on the ULACC website. If the animals are to be 
euthanized, please describe the agent and method employed. Decapitation or cervical 
dislocation without anesthesia requires written justification below.] 
  
  Animal Transfer: 
 
_____ Internal to another AUP (requires ULACC approval) 
 
_____ External (outside agency, slaughter, adoption, etc.) 
 
  
If adopting animals to private homes, please provide your laboratory procedures and 
guidelines. 
Transfer to a private destination requires prior approval. Assure appropriate drug 
withdrawal times if applicable. 
 
 
Euthanasia (This section must be completed on all AUP’s.  *Exceptions must be clearly 
explained (e.g. protected species).  
  
 Method: lethal overdose 
   
 Agent: sodium pentobarbital 
   
 Dose: 120 mg/kg    Route: IP  
Justification of decapitation / cervical dislocation without anesthesia, if employed:     
 
Even when euthanasia is not an integral part of the AUP, please provide an adequate 
protocol for euthanasia in case there is an unexpected event. 
 
F. Name(s) of individuals(s) administering euthanasia. [Note: Other than CMP or Vet 
Med Park staff, only the persons listed below will be authorized to perform the euthanasia 
procedure.]        
 David C. Zawieja, Anatoliy Gashev, Steven Greiner 
 
G. Specify the education, training and experience which qualifies each person named in 
Section IIF to perform euthanasia.     
David C. Zawieja, Ph.D., 22 years experience with rat models, TAMU LARR training “Rats: 
Basic Handling and Techniques” and “Asepsis and Aseptic Techniques”.  
Anatoliy Gashev, M.D. Ph.D., 19 years experience with rat models, TAMU LARR training 
“Rats: Basic Handling and Techniques”. 
 Steven Greiner, D.V.M., 9 years experience with rat models, TAMU LARR training “Rats: 
Basic Handling and Techniques”, TAMU LARR training “Mice, Basic Handling & Techniques” 
SECTION III. ANIMAL PROCEDURES 
 
A. Where will you conduct animal procedural/teaching work? [List Bldg. and Room # for 
each procedure to be done]: Reynolds Medical Bldg. Room 347 
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B. Briefly indicate below any non-surgical procedures to be used. Identify each species 
involved [If more than one]: 
 
1. Method & duration of restraint: 
 The rats will be briefly manually restrained, no more than a minute or two, in order to give the 
anesthetic drugs 
 
2. Method of obtaining blood or other tissues: [Indicate the technique to be used, the 
volume to be collected, the frequency of collection, and the interval between collections. 
Terminal blood collections require use of a suitable anesthetic.] 
Lymphatic tissues will be collected after anesthesia, see details in Attachment 1 
Surgical Procedures 
 
3. Agents to be administered (other than anesthetics/adjuvants), including dose, volume, 
route, & frequency: 
NA 
4. Other procedures such as food or water deprivation, administration of noxious stimuli 
or substances and procedures which might induce clinical illness. 
The animals will be fasted overnight the day before they are used. This is important for our 
studies in order to study basal lymphatic function under fasted conditions. We have extensive 
experience with this brief period of fasting and have not seen problems associated with it. 
 
5. Names and qualifications of personnel to perform the specified procedures (Include 
training and experience in the techniques listed above):        
David C. Zawieja, Ph.D., 22 years experience with rat models, TAMU LARR training “Rats: 
Basic Handling and Techniques” and “Asepsis and Aseptic Techniques”.  
Anatoliy Gashev, M.D. Ph.D., 19 years experience with rat models, TAMU LARR training 
“Rats: Basic Handling and Techniques”. 
Steven Greiner, D.V.M., 9 years experience with rat models, TAMU LARR training “Rats: Basic 
Handling and Techniques”, TAMU LARR training “Mice, Basic Handling & Techniques” 
 
C.  Anesthesia/Analgesia 
 
1. If anesthesia is necessary, please describe the agent to be used, dosage and route of 
administration for each species. [Also indicate any other pre-anesthetic procedures, such as 
duration of fasting from food and water. Repeat for each species and/or surgical procedure if 
different.] 
 
 Preanesthetic: none  Dosage:  NA  Route:   NA  
 The animals will be fasted overnight the day before they are used. This is important for 
our studies in order to study basal lymphatic function under fasted conditions. We have 
extensive experience with this brief period of fasting and have not seen problems associated 
with it. 
 
 Anesthetic: Fentanyl-Droperidol   Dosage: 0.3 ml/kg  Route: IM  
 Muscle relaxant:     Diazepam      Dosage:  2.5 mg/kg     
Route: IM 
 
(the initial anesthetic dose is indicated in the LARR Animal Care and Use Handbook 
from TAMU and TAES and after extensive consultation and collaboration with LARR 
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veterinarian Dr. Kasari to find an anesthetic regimen that provides appropriate 
anesthesia/analgesia without inhibiting the lymphatic function we are scientifically 
trying to evaluate. It has been shown that of the typical drugs used for surgical 
anesthesia the barbituates, and gas anesthetics (other than ether) when “used in doses 
similar to plasma levels found during general anaesthesia, significantly depressed 
lymphatic contractility” (McHale NG and Thornbury KD. The effect of anesthetics on 
lymphatic contractility. Microvasc Res 37: 70-76, 1989). Thus we CANNOT use 
barbiturates, halothane of isoflurane anesthetics for these studies as they will render the 
results useless. We take care to test stimulatory reflexes of the rats to ensure that the 
animals are at an appropriate stage (III) and plane (2-3) of anesthesia and without 
normal responses to noxious stimuli (close hand clap, tail pinch and palpebral reflex). 
If the animal is not at an appropriate level of anesthesia/analgesia we will redose, 
although our experience for this regimen and experiment indicates this is usually not 
needed. In the past we have used a ketamine-xylazine mixture (100-300 mg/kg) for 
some experiments. However, we did not include this anesthetic regimen in this AUP 
because often the time needed to study/isolate the lymphatics for these experiments is 
longer (45-60 minutes) than what was indicated to us (as well as what we 
experimentally observed) was the optimum length of appropriate surgical plane (15-30 
minutes) for ketamine-xylazine mixture regimen,  thus requiring at least one redosing. 
This appeared to us to increase, not decrease the likelihood that our animals may 
experience pain during the procedure. Thus after careful consideration of all these 
factors we opted to use the Fentayl-Droperidol anesthetic regimen.) 
 
 Analgesics:  Dosage:    Route:  
 
2. Identify each person who will administer/monitor anesthesia and their qualifications.  
[Indicate previous experience, education, and specific training for this specie and with this 
anesthetic agent.   A listing of academic degrees is not an adequate response to this question. 
Anesthesia training is available; for information on training, visit the ULACC website, 
http://animal.tamu.edu/training.html.  In teaching activities, students under the direct 
supervision of qualified personnel may be appropriate.]: 
 
David C. Zawieja, Ph.D., 22 years experience with rat models, 7 years experience with this 
anesthetic & species TAMU LARR training “Rats: Basic Handling and Techniques” and 
“Asepsis and Aseptic Techniques”.  
Anatoliy Gashev, M.D. Ph.D., 19 years experience with rat models, 5 years experience with 
this anesthetic & species, TAMU LARR training “Rats: Basic Handling and Techniques”. 
Steven Greiner, D.V.M., 9 years experience with rat models, 4 years experience with this 
anesthetic & species, TAMU LARR training “Rats: Basic Handling and Techniques”, TAMU 
LARR training “Mice, Basic Handling & Techniques” 
 
D. Assessment of Pain and Distress 
 
1. Does the project/class exercise involve the use of painful procedures or paralytic drugs 
without the benefit of anesthetics or analgesics? Yes           No ___X___ 
 IF YES, justify why anesthetics/analgesics are inappropriate for your experiments:        
 
2. Could the procedures or outcome of this project/class cause more than slight or 
momentary pain or distress to animal subjects?  Be advised that the USDA has ruled that 
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any surgical procedure has the potential for pain and/or distress.  (Please see the ULACC 
Website at http://animal.tamu.edu/p&d.html for examples of procedures which may cause pain 
or distress.) 
   
  NO  _____ 
 
  YES __X__ (Complete below) 
 
  A. __X__ As described in Section III.D.I. any potential pain or distress to 
these procedures will be relieved through use of anesthetics and analgesics and alternatives to 
these procedures are not available. COMPLETE THE SECTION ON ALTERNATIVES 
BELOW 
 
  B. _____But as described in Section III.D.I., anesthetics and analgesics are 
inappropriate for these procedures. Alternatives to these procedures are not available.  
COMPLETE THE SECTION ON ALTERNATIVES BELOW 
 
Describe the methods and sources you used to determine that alternatives to these procedures 
are not available. These might include computerized database searches (BIOSYS, Current 
Contents, Medline, PubMed, AgriCola).  Be advised that database searches are not the only 
source of alternatives.         
 
 Databases searched: Medline, PubMed 
      
 Dates searched (inclusive): 1966-2004 
      
 Keywords: lymphatic function, animal models, alternatives 
      
A narrative of the results of alternatives search, addressing Refinement (new anesthetics, new 
analgesics, new surgical techniques, etc.) Reduction (please feel free to include reduction in 
numbers that have occurred during your career), Replacement (non-animal techniques) and a 
justification as to why these options were not used is required: We have looked in the 
literature and consulted with Dr. Kasari from LARR for better refinements of 
anesthetics/analgesics and were not able to find significant refinement of these options 
given the scientific problems associated with most other anesthetics and lymphatic 
function. In terms of reduction of animal numbers over the course of my career here we 
have significantly reduced our numbers through refinement of expertise and technique to 
the point where the numbers needed reflect the true biological variability of the 
lymphatic biology and not our capabilities to accurately perform these studies. 
Replacement is simply not a viable alternative for these studies. While we use cell cultures 
for certain aspects of similar work, cultured cell DO NOT reflect what happens in situ in 
these tissues. Computer models are too simple and can truly only predict what we already 
know and that is not what our studies represent. 
 
3. Is there a possibility of any illness in the animals as a result of experimental/teaching 
procedures? Please include any clinically significant side effects that may occur in genetically 
modified animals.  
 No   X       Yes ______ if yes answer a-d below: 
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a. describe those effects and explain at what point and by what objective criteria (such as 
clinical      condition) the animals may be euthanized or permanently removed from the 
study/class:     
B. describe the frequency per day that you or your staff will observe the animals after 
treatment administration: 
C. describe the monitoring and recording procedures for determining physiological or 
behavioral abnormalities:      
D.   State what measures will be taken to minimize or alleviate problems associated with 
experimental/teaching procedures: 
 
   
4. Is death (without euthanasia) an endpoint of the study? Yes         No __X___  
IF YES, justify why an earlier end point is not acceptable: 
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ATTACHMENT 1 
SURGICAL PROCEDURE 
 
Instruction to Investigator/Instructor:  Fill out one copy of this page for each different 
surgical procedure. Please make an entry for each category. Carefully list the personnel 
names for those who will monitor anesthesia, conduct the surgery and monitor recovery. Only 
those persons listed below will be authorized to perform these functions. All survival surgical 
procedures require use of aseptic technique. This includes use of sterile surgical gloves, sterile 
instruments and aseptic preparation of the surgical field. 
 
A. Surgical Procedure:  Specify: __Laparotomy___ 
 
1. Where will the surgery be performed? [List Bldg, Room #]: 
 Reynolds, room 347 
2. Indicate the nature of the surgical procedure [check one]: 
 
     X   Non-survival 
          Survival 
           Multiple Major Survival [Provide justification]:      
 
3. Provide a brief description of the surgical procedure [Include relevant details from 
initial incision to wound closure.]:        
A 2 cm long midline abdominal incision will be made through the skin, underlying fascia, and 
abdominal muscle layers. Bleeding will be controlled by electrocautery. A loop of small 
intestine, 4-5 cm long, will be gently exteriorized onto a specially designed preparation board 
so access to mesenteric collecting lymphatics is possible for observation  and tissue collection. 
The exposed tissue will be continuously superfused with warm (37°C) physiological buffer. 
This preparation will be briefly observed with the aid of a stereomicrosope to pick a lymphatic 
suitable for isolation.  The vessel will then be carefully dissected free from the surrounding 
tissue. After tissue collection, the animals are euthanized as described earlier. 
 
4. Identify each person who is authorized to perform the surgical procedure. Indicate the 
qualifications of each person who will conduct the surgical procedure. [Indicate previous 
experience, education, and specific training for performing the procedure. A listing of 
academic degrees nor curriculum vitae (CV’s) are an adequate response to this question. 
Surgical training is available; for information on training, visit the ULACC website, 
http://animal.tamu.edu/training.html.  In teaching activities, students under the direct 
supervision of qualified personnel may be appropriate.]: 
David C. Zawieja, Ph.D., 22 years experience with rat models, TAMU LARR training “Rats: 
Basic Handling and Techniques” and “Asepsis and Aseptic Techniques”, “Mice, Basic Handling 
& Techniques”, “Asepsis and Aseptic Techniques”.  
Anatoliy Gashev, M.D. Ph.D., 19 years experience with rat models, TAMU LARR training 
“Rats: Basic Handling and Techniques”, TAMU LARR training “Mice, Basic Handling & 
Techniques” Asepsis and Aseptic Techniques”.  
Steven Greiner, D.V.M., 9 years experience with rat models, TAMU LARR training “Rats: Basic 
Handling and Techniques”, TAMU LARR training “Mice, Basic Handling & Techniques”, 
“Asepsis and Aseptic Techniques”. 
 
B. Post Operative Care:  
1. Where will the animals recover from surgery? [List Bldg, Room #]:        
NA 
176 
2. Indicate what post-surgery complications might be anticipated and how they will be 
managed:        
NA 
3. List the names of the individuals who will monitor post-operative recovery and 
frequency of observation:       NA 
4. Describe the post-operative medication(s) to be given. [List each agent, the dosage 
(e.g. mg/kg), route (e.g. IP) and  the frequency of administration.  If no analgesics are planned, 
please justify withholding analgesics following any surgical procedure.]: NA 
  Analgesics:        
  Antibiotics:       
 
   Other:    
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ATTACHMENT 2 
ANTIBODY PRODUCTION 
 
Instructions to Investigator:  Appropriate use of any adjuvant involves minimization of volume 
for injection and maintenance of sterility of material to be injected. Please contact one of the 
CMP veterinarians  
(845-7433) if you need more information.  NOTE: USDA has determined that the use of 
Freund’s complete adjuvant has the potential to cause more than momentary or slight pain or 
distress.  If you plan to use Freund’s complete, please answer “YES” to question III.D.2. on the 
AUP and document your search for alternatives. NA 
 
A. Describe your immunization protocol. [Please include adjuvant to be used including 
justification if complete Freund’s is required. The committee discourages the use of Freund’s 
Adjuvant due to the tendency of Freund’s to contribute to tissue damage. Describe the route, 
volume, and number of sites for injections as well as time intervals between injections.]:        
 
 
B. Describe route and volume of blood collection and interval between collections. [Note: 
Volume and frequency of collection must be limited to that which causes no anemia or 
hypovolemia. If there are questions concerning safe volumes, please contact one of the CMP 
veterinarians. Exsanguination must be performed under general anesthesia. Bleeding from the 
orbital sinus of rodents should be performed under anesthesia. Special authorization may be 
provided to individuals with experience and technical expertise for performance of orbital 
sinus bleeds without anesthesia.]       
 
 
C. Describe ascites fluid collection procedures. [Note: After inoculation for ascites 
production, animals should be observed at least 3 times per week the first week and daily 
thereafter by the PI or the PI's staff to monitor the degree of abdominal distention and illness. 
Fluid should be removed when distention is comparable to a term pregnancy. Only one 
survival tap followed by one terminal tap under anesthesia is recommended. Euthanasia 
should be performed on any animals showing signs of poor condition.  NIH expects that if the 
ascites method is to be used, justification is provided for why in vitro alternatives are not 
suitable.]   
 
 
D. Name(s) and qualifications of individual(s) performing techniques described including 
injections, abdominal taps, anesthesia, and blood collection. [Include education, training and 
experience in these techniques.]       
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ATTACHMENT 3 
APPROVAL FOR USE OF HAZARDOUS MATERIALS IN ANIMALS 
 
Instruction to Investigator/Instructor:  If you will be using any hazardous substances (e.g., 
radioactive materials, toxic chemicals) in your animals (in vivo), you must complete this page.  
We will forward it on your behalf to the appropriate safety official.  Do not use this form for 
infectious agents.  Obtain separate IBC approval. NA 
 
INVESTIGATOR/INSTRUCTOR:           DEPT.:                   AUP #:            
(to be assigned by ULACC) 
 
PROTOCOL TITLE:    
 
AGENT(S) TO BE USED:       
 
SPECIES TO BE USED: 
 
ANIMAL HOUSING SITE (include Bldg. & room. #):      
 
LOCATION OF LABORATORY: 
 
DESCRIPTION OF PROPOSED ACTIVITY: 
 
How is the agent to be introduced into the animal? 
        topical           oral           inhalation           injection      (give route, volume and 
concentration) 
 
Major containment equipment to be used for personnel protection:        
 
Personal protective gear to be worn: 
       Face Shield         Goggles         Face Mask         Full Face Respirator          Shoe Covers         
Lab Coats 
       Rubber Boots/Coveralls          Other (specify): 
 
Describe type and quantity of hazardous waste to be generated and method of disposal:  
       
Describe how contaminated materials are to be treated after usage (animals, bedding, 
glassware, benchtops, hoods, etc.):       
 
Indicate which of the following resources are available in the area the procedure will be 
performed 
       Fire Extinguisher         Eyewash Station         Spill Kit         Emergency shower 
 
Describe emergency procedures to be followed in case of accident (personnel exposure, spill, 
fire, etc.)     
    
Last date of certification for any hood required:        
 
Qualifications of Involved Personnel (give names, experience, certifications, etc.):       
ATTACHMENT 4 
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FIELD STUDIES 
 
Assurance of Health and Safety  
of  
Personnel Performing Field Studies Involving Animals 
 
 
Instructions to Investigator/Instructor: The purpose of this Attachment is to assure that 
consideration is given to safety and well being of university personnel participating in field 
studies.  It is a part of the institutional compliance with the Guide for the Care and Use of 
Laboratory Animals and the Guide for the Care and Use of Agricultural Animals in 
Agricultural Research and Teaching. 
 
I hereby certify that there is a program in place to assure the safety of personnel 
participating in this proposed work. The program involves hazard identification and risk 
assessment, appropriate equipment for safe conditions for the work, personnel training 
and education, and preventive medical oversight. It includes an emergency plan which 
covers the following: 
 
A mechanism to evacuate personnel if necessary in a timely fashion 
 
A permanent and dependable system such as telephone, cellular phone, or radio for continuous 
emergency communication capability 
 
A local contact for health and safety emergencies 
 
Necessary medical coverage (insurance) 
 
Appropriate individual medical preparedness  
 
Vaccine and preventive medical precautions as deemed necessary by a physician 
 
Adequate supplies of prescription drugs/devices 
 
First Aid and Cardiopulmonary Resuscitation skills 
 
Method to assure contact of University Human Resources Department in the event of 
accident/injury 
 
Credentials and or training in safety procedures necessary for carrying out the work as 
determined by the Principal Investigator 
 
________________________________________  
 __________________ 
Signature of Investigator/Instructor      Date 
(Signature does not imply transfer of liability) 
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Experimental Design Addendum 
 
The following table describes our projection of the number of animals needed for each 
of the experimental Project originally described in this proposal. However since this 
grant has been active for almost 2 years some of the projects have been completed and 
some have been removed from the grant due to funding limitations. The table below 
thus only reflects the animals needed for those projects still left to be finished. 
 
 
Project # # of groups # of animals/group Total # /Project 
1 1 Completed in years 1-2 
2 1 Completed in years 1-2 
3 1 15 15 
4 1 15 15 
5 1 Project removed in renewal 
6 1 Project removed in renewal 
7^ 20 15 300 
8* 5 20 100 
Total number of animals for the remainder of the proposal equals  430 
 
* Project 8 will require 20 animals per group because of anticipated potential 
difficulties in the proposed research paradigm briefly described below:  
Project 8: "Measure the changes in intracellular calcium in the endothelial and muscle 
cells of isolated mesenteric lymphatic that occur in response to imposed flow" has 5 
experimental groups (endothelial calcium measurement, smooth muscle calcium 
measurement, endothelial denuded smooth muscle calcium measurement, SNP group 
with smooth muscle calcium measurement and DEA-NONOate group with smooth 
muscle calcium measurement) all of which require the measurement of intracellular 
calcium in intact tissues and thus are more difficult experiments based on our previous 
studies. Thus we anticipate needing larger number of animals in these groups. 
 
^ Project 7 is an extensive project (20 experimental groups) that is the heart of this 
proposal that investigates the roles of nitric oxide (NO) pathway, the prostanoid 
pathways, and the EDHF pathways in the flow-mediated effects on lymphatic 
contractile function. There are 4 different groups studying the role of nitric oxide, 8 
different groups studying the role of prostanoid, and 8 different groups studying the 
role of EDHF pathways. 20 experimental groups times 15 animals per group yields 300 
animals for this project. 
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